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ABSTRACT
Dopamine is critical for processing of reward and etiology of drug addiction.
Astrocytes throughout the brain express dopamine receptors, but consequences
of astrocytic dopamine receptor signaling are not well established. This thesis
illustrates effects of dopamine on cultured astrocytes and astrocytes in brain slices
(ex vivo). In striatal cultures, extracellular dopamine triggered changes in astrocytic
Ca2+ signaling and rapid concentration-dependent stellation of astrocytic
processes that was not a result of dopamine oxidation, but instead relied on both
cAMP-dependent and cAMP-independent dopamine receptor signaling. To isolate
possible mechanisms underlying these structural and functional changes, wholegenome RNA sequencing was used in identifying prominent dopamine-induced
enrichment of genes containing the CCCTC-binding factor (CTCF) motif,
suggesting involvement of chromatin restructuring in the nucleus. Specifically,
results show that cultured astrocyte response to elevated dopamine involves
PARP1-mediated CTCF genomic restructuring and concerted expression of gene
networks. To examine astrocyte response to behaviorally relevant dopamine
signals, astrocyte morphological and molecular profiles in ventral striatum (nucleus
accumbens core; NAcC) and dorsolateral striatum were characterized following
cocaine self-administration training on an extended access schedule. Findings
illustrate that extended cocaine experience resulted in decreased numbers of
GFAP+ cells and primary process number in the ventral striatum. This was
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associated with an increase in connexin 30 mRNA, an astrocyte-astrocyte
interaction gene. In the dorsolateral striatum, there was an observed increase in
length of GFAP+ primary processes and downregulation of SPARC (astrocyteneuron interaction gene) mRNA.
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CHAPTER 1
GENERAL INTRODUCTION
First noted in 1824 and first named in 1856, glia have long been
acknowledged in neuroscientific literature (Virchow, 1856). Rudolf Virchow was the
first to apply a name to these cells, designating them as neuroglia or “nerve-glue”
(Virchow, 1856). For many years, neuroglia were regarded as inert cells charged
with providing structural support in order for neurons to function. Yet, neuroglia or
glia are now understood to play a multitude of diverse and crucial roles in the brain
ranging from immune responses to regulation of neural networks. Neuroglia
comprise an expansive population of brain cells (80 - 90%), and can be grouped
based on developmental origin, morphology, and function into two main classes:
microglia and macroglia (Ramon y Cajal S., 1913; Kandel et al., 2012; Oberheim
et al., 2012). Cells classified as macroglia include astrocytes, oligodendrocytes,
and oligodendrocyte precursor cells. Astrocytes and oligodendrocytes have
discrete functional responsibilities. While oligodendrocytes ensheath CNS axons
in myelin to promote rapid saltatory conduction, astrocytes are understood to play
particularly diverse roles within the brain (Haydon et al., 2009; Oberheim et al.,
2012; Araque et al., 2014). One of the interesting observations emerging over the

Galloway, A. G.*, Adeluyi, A. A.*, O’Donovan, B., Fisher, M. L., Rao, C. N…. & Ortinski,
P. I. (2018). Dopamine triggers CTCF-dependent morphological and genomic
remodeling of astrocytes. Journal of Neuroscience. Reprinted here with permission from
publisher. * indicates equal contributions
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last few decades is that astrocytes can regulate neuronal activity. For example,
Jones et al. (2011) found that astrocyte-secreted SPARC is stimulated by
extracellular glutamate which negatively regulates synaptic AMPA receptor
expression levels. This allows for a homeostatic mechanism of controlling synaptic
excitability, by which increased environmental excitability (i.e., rise in glutamate)
decreases synaptic excitability via astrocytes.
Astrocyte heterogeneity in form and function, both across and within brain
regions, allows for refined and specialized structural and functional astrocyteneuron interactions with implications for overall brain function and behavior. In fact,
recent evidence has shown structural differences in astrocyte-neuron interactions
in the mouse hippocampus and striatum. Specifically, a single astrocytic territory
(which includes the cell body and associated processes) within the striatum was
found to encompass up to 20 neuronal cell bodies. Yet, in the in-tact hippocampus,
a single astrocyte could contain, at most, a single neuron. Moreover, astrocytic
territories in the hippocampus were also found to interact with a significantly larger
number of excitatory synapses with distinctions in individual astrocyte functional
profiles evidenced by Ca2+ imaging analyses (Chai et al., 2017). Thus, the
heterogeneous and complex nature of astrocytes in distinct brain regions and brain
circuits begs for advanced techniques in investigating the morphological and
functional elaborations and aberrations of these cells, as well as their role in
regulating neuronal activity via astrocyte-released transmitters and molecules. The
experiments and results presented in this thesis explore how astrocytes respond
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to dopamine, a molecule critical for regulation of synaptic plasticity underlying drug
dependence disorders.

1.1

Dopaminergic neurotransmission
Dopamine exerts its physiological effects through stimulation of D1- like

(DRD1, DRD5) or D2-like (DRD2, DRD3, DRD4) metabotropic G-protein coupled
receptors (Figure 1.1). Dopamine receptors span the plasma membrane 7 times
and have a cytoplasmic domain that binds to and interacts with Gα and Gβγ
proteins, as well as an extracellular domain that exclusively binds dopamine
(Iversen et al., 2009; Kandel et al., 2012). Ligand binding to D1-like receptors
stimulates Gαs/olf subunit containing G-proteins that dissociate to Gβγ and
Gαolf/s-GTP. Gαolf/s-GTP then stimulates the enzyme, adenylyl cyclase (AC)
which synthesizes and increases the concentration of cyclic AMP (cAMP). In turn,
cAMP activates protein kinase A (PKA) which will go on to phosphorylate various
targets (Kandel et al., 2012; Iversen et al., 2009). In contrast, D2-like receptors
inhibit AC through activation of Gαi/o subunit containing G-proteins. Activation of
D2-like receptors leads to inhibition of the AC/cAMP/PKA signaling pathway.
Activation of D2-like receptors also results in Gβγ-mediated activation of PLC
(Phospholipase C) resulting in upregulated IP3 (Inositol triphosphate) production.
Increases in IP3 generation gives rise to the release of ER Ca2+, and the
subsequent inactivation of L-type Ca2+ channels and Na+ channels (Kandel et al.,
2012; Iversen et al., 2009). DRD1s and DRD2s can oligomerize to form
heteroreceptors in certain populations of cells. For example, D1/D2 heteromeric
receptors have been found in striatal neurons within the rat CNS (Hasbi et al.,
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2011). Ligand binding to D1/D2 heteromers causes a Gαq-mediated increase in
intracellular Ca2+ in a PLC-dependent manner (Lee et al., 2004; Rashid et al.,
2007).

1.2

Motivation, reward, and memory
Dopamine serves as a critical neurotransmitter of the CNS, playing

important roles in regulating movement, as well as learning and motivation. Ever
since its original discovery, the dopaminergic system and its intricate signaling
networks have and continue to be a topic of exhaustive scientific and clinical
investigation. Moreover, it is widely recognized for its role in various
neurobiological disorders involving movement-related deficits (i.e., Parkinson’s)
and addiction (Iversen et al., 2009).
The mesolimbic dopamine system serves as a key determinant of
motivation and incentive salience, regulating an individual’s response to natural
rewards, such as food and social interaction (Figure 1.2). The ventral striatum or
nucleus accumbens (NAc) comprises both core (NAcC) and shell (NAcS)
components and is the principal target innervated by dopamine neurons located in
the ventral tegmental area (VTA). The ventral striatum partners with memory and
executive function-related centers of the brain, including the hippocampus and the
frontal lobe, by processing prominent glutamatergic inputs from both areas. In the
hippocampus, dopamine is crucial for encoding/consolidating information into
long-term declarative/explicit memory (Milner et al., 1998; Pennartz et al., 2011).
In the frontal lobe, dopamine works to regulate executive control over decisions of
whether or not the reward should be pursued (Bechara, 2001: Volkow et al., 2002;
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Zahrt et al., 1997). These brain regions do not work independently, but rather
function in a highly interactive manner to mediate an individual’s response to
various environmental stimuli.

1.3

Roles of the hippocampus and striatum: implications in disease
Dopaminergic neurons populate two neighboring subregions of the ventral

mesencephalon: the Substantia Nigra (SN) and Ventral Tegmental Area (VTA;
Hokfelt et al., 1984; Figure 1.2). Three target areas, the striatum, the limbic
system, and the frontal cortices, receive efferent projections from one of the two
above mentioned midbrain regions (Hokfelt et al., 1984; Kandel et al., 2012). Each
pathway formed by these projections subserves a different set of functions and is
consequently implicated in distinct neuropathologies. Dopaminergic fibers
stemming from the more lateral region of the substantia nigra pars reticulata (SNr)
form the nigro-striatal system, a system involved in production/initiation of
movement, by forming functionally distinct parallel-processing loops with the basal
ganglia (Iversen et al., 2009). Deficits in this system lead to significant deficits in
motor control (i.e., tremors, rigidity, postural imbalance) a pathological marker of
Parkinson’s disease (Kandel et al., 2012). The mesocortical pathway originates in
the VTA and terminates in the prefrontal cortex (PFC), and is involved in higher
cognitive processes such as working memory and goal-directed behaviors (Zahrt
et al., 1997). The mesolimbic system sends projections from the VTA to the
nucleus accumbens (NAc) of the limbic system. Pathological disturbance of this
pathway has been implicated in schizophrenia, obsessive-compulsive disorder,
and drug addiction. A pathway directed from the PFC to the VTA and limbic system
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provides a circuit encompassing both the mesocortical and mesolimbic
projections. The mesolimbic pathway has been acknowledged as a regulator of
sensitized incentive salience or ‘wanting’ through action in the amygdala, as well
as, memory consolidation in the hippocampus (Robinson and Berridge, 2008; Li et
al., 2003; Da Silva et al., 2012). Addictive substances upregulate dopaminergic
activity within this complex reward system, resulting in pathologically high reward
values being assigned to cues that co-occur with drug activity (Iversen et al., 2009;
Kandel et al, 2012).
Strong evidence indicates a role for the hippocampal-temporal lobe system
in declarative memory and the striatum and basal ganglia components in
procedural learning and habit formation (Packard & McGaugh, 1992; McDonald &
White, 1993; Yin & Knowlton, 2006; Pennartz et al., 2011). While the particular
functions of the hippocampus (Hipp) are not fully understood, evidence shows a
role of the Hipp in episodic memory, which encodes information about individually
experienced events set in specific spatiotemporal context (Tulving & Markowitsch,
1998; Eichenbaum et al., 2007; Wang & Morris, 2010; Squire & Wixtted, 2011). In
contrast, procedural memories are believed to be encoded by synaptic activities in
the cortico-basal ganglia-thalamic loops. These circuits connect neocortical areas
unidirectionally to striatal subregions, which then project to downstream structures
such as the ventral pallidum (VP), ventral tegmental area (VTA), substantia nigra
pars reticulata (SNr) and pars compacta (SNc). These components connect to
thalamic nuclei that send projections back to the same general neocortical areas
of circuit origin. Studies have identified various parallel loops associated with
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different forms of motor and cognitive processes. Motor and oculomotor loops
originate in the frontal eye fields and pre-motor cortices, and cognitive and
motivational-affective loops are associated with the prefrontal cortex (PFC),
amygdala, and the hippocampus (Alexander et al., 1990; Nambu, 2008; Pennartz
et al., 2011).
The striatum can be subdivided into several subregions: the dorsolateral
striatum (DLStr) mediates stimulus-response learning and habit formation, the
dorsomedial striatum (DMStr) is implicated in cognitive functions and actionoutcome learning, and the ventral striatum or nucleus accumbens (NAc) is involved
in motivational and affective behavioral processing (Packard & McGaugh, 1992;
Knowlton, 2006; Corbit & Belleine, 2003; Voorn et al., 2004; Pennartz et al., 2011;
Everitt & Robbins, 2005; Yin et al., 2005; Graybiel, 2008; Balleine et al., 2009;
Yager et al., 2015). The question of how striatal integration of hippocampal inputs
with afferents from other areas governs motivational processes in models of
reinforcement learning remains an important field of research.
Dopamine release in the ventral striatum plays an essential role in
mediating affective regulation over motivated behaviors, and its dysregulation may
contribute to disorders commonly associated with dysregulated dopaminergic
signaling such as substance use disorders. The involvement of the ventral striatum
in the reinforcing effects of drugs of abuse, such as cocaine, has led to this region
being associated with addiction (Russo et al., 2010). Evidence supports the role
for the ventral striatum in drug-seeking behavior in animal models of drug selfadministration (Everitt & Robbins, 2005) due to its mediation of motivational effects

7

of conditioned stimuli associated with the drug itself. Emerging studies reveal that
this region plays a particularly important role in the early development of drugtaking and drug-seeking behaviors. Acute elevation of extracellular dopamine in
the ventral straitum, but not the dorsal striatum, potentiates effects of conditioned
reinforcers on lever pressing in animal operant conditioning/drug selfadministration models (Di Ciano et al., 2008; Taylor & Robbins, 1984). Moreover,
selective dopamine elevation by drug infusion in the NAcS of the ventral striatum
has been shown to increase Hipp-dependent control over conditioned place
preference (CPP). In contrast, when dopamine was directly elevated in the NAcC
of the ventral striatum, Hipp-dependent control over CPP-related learning was
attenuated (Ito & Hayen, 2011). These findings illustrate regional and sub-regional
differences in the way dopamine regulates limbic information processing to
mediate individuals’ responses to environmental stimuli (Ito & Hayen, 2011).
Taken together, evidence supports the theory of distinct cortico-striatal
loops associated with processing different forms of incoming associative
information. It has been established that the hippocampal-ventral striatal pathway
is critical for associating contextual-positional information. Moreover, dopamine
selectively regulates the strength or gain of associative control over motivated
behavior in a sub-region-specific manner.

1.4

Striatum: subregion distinctions in cognition and motor function
GABAergic medium spiny neurons represent the majority of striatal neurons

(MSNs; Kemp & Powell, 1971; Gerfen, 2004; Yager et al., 2015). In the dorsal
striatum, two MSN populations exist and are classified based on their projection
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patterns to the basal ganglia output nuclei and presence of certain neuropeptides
and receptors (Figure 1.3). Direct pathway MSNs (dMSNs) send projections to the
subtantia nigra reticulata (SNr) and globus pallidus internal (GPi), and express
dopamine D1 receptors (Gerfen & Surmeier, 2011; Wall et al., 2013; Yager et al.,
2015). Indirect pathway MSNs (iMSNs) project to the globus pallidus external
(GPe) and the subthalamic nucleus (STN), and express dopamine D2 receptors
(Gerfen & Surmeier, 2011; Wall et al., 2013; Yager et al., 2015). Activation of direct
MSNs (dMSNs) allows for initiation of intended behavior or movement. In contrast,
iMSNs, when activated, work to inhibit unwanted behavior or movement (Yager et
al., 2015; Lee et al., 2016). In the ventral striatum, these same MSNs and output
pathways are present; however, the efferent targets of these MSNs differ from
those in the dorsal striatum and the pathway distinctions are less understood.
Specifically, iMSNs in the ventral striatum project to the ventral pallidum and
dMSNs project to the VTA and SNr (Chang & Kitai, 1985; Lu et al., 1998; Zhou
etal., 2003, Tripathi et al., 2010; Yager et al., 2015).
With these anatomical differences, there are also functional differences
between the two striatal subregions (Haber & McFarland, 1999; Berke & Hyman,
2000; Haber, 2003, Pennartz et al., 2011). The ventral striatum is associated with
limbic areas of the brain and regulates affective behavioral components, including
motivation and emotion (Berke & Hyman, 2000; Meredith et al., 2008;
Groenewegen & Trimble, 2007; Pennartz et al., 2011; Yager et al., 2015). Neurons
in the NAcC and NAcS subdivisions of the ventral striatum also differ functionally.
The NAcC is involved in the processing of conditioned stimuli and the NAcS is
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essential in the processing of unconditioned stimuli. These distinctions are thought,
in part, to be a result of heterogeneity in neuron morphology and projection
patterns of these ventral striatal subdivisions (Heimer et al., 1997, Groenewegen
et al., 1999, Meredith et al., 2008).
The two subdivisions of the dorsal striatum, dorsomedial and dorsolateral,
both receive dense innervation from neocortical regions, including areas involved
in motor processes (Berke & Hyman, 2000). The dorsomedial striatum is essential
in output of goal-directed behaviors, whereas the dorsolateral striatum is thought
to regulate habitual behavior (Everitt & Robbins, 2005; Pennartz et al., 2011; Yager
et al., 2015). Importantly, these striatal sub-regions are not functionally
independent, as limbic and cortical information can be passed from the NAcS,
through the NAcC to the dorsal striatum in an ascending spiral via midbrain (VTA)
dopamine neurons (Haber et al., 2000; Yager et al., 2015). This understanding
provides important implications for the functional and behavioral development and
persistence of addictive-like behaviors.

1.5

Dopamine and substance abuse in the striatum: evolution of addiction
During the development of drug addiction, drug behavior evolves from

voluntary drug-seeking to compulsive drug-seeking behavior. This progression
from voluntary to compulsive drug seeking in rodents is associated with continued
drug self-administration despite aversive stimuli or consequences (e.g. mild foot
shock) and can be observed following chronic, but not short periods of exposure
to the drug (Yager et al., 2015; Vanderschuren & Everitt, 2004). These behavioral
adaptations are associated with a transfer of control over drug-seeking behavior
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from the ventral striatum to the dorsal striatum (Vanderschuren & Everitt, 2004;
Everitt & Robbins, 2013). The ventral-to-dorsal striatum shift in controI over drug
seeking can be seen as increase in DA efflux within the dorsolateral (DL) striatum,
but not within the ventral striatum (Everitt & Robbins, 2013; Ito et al., 2002; Wilhuhn
et al., 2012). In fact, lesions or dopaminergic denervation of the dorsolateral
striatum disrupt both acquisition and maintenance of compulsive drug-seeking and
drug-taking behaviors (Belin & Everitt, 2008; Yin et al., 2006; Faure et al., 2005).
Taken together, these findings reveal that extended cocaine taking leads to
compulsive drug-seeking habits which are associated with progressive
involvement of dorsal striatal components.
Distinct neuronal changes in the molecular, cellular, and structural
mechanisms have been established within the dorsal striatum following extended
cocaine self-administration regimes (Everitt & Robbins, 2013; Everitt & Robbins
2005; Jonkman & Kenny, 2013). However, non-neuronal mechanisms and
machinery which underlie the switch to habitual drug-seeking characteristic of
addiction have not yet been explored.

1.6

Astrocyte morphology
Studies in brain slices and cell cultures derived from different brain regions

have illustrated that astrocytes are pharmacologically, morphologically, and
functionally heterogeneous, and that different subtypes of astrocytes are
electrophysiologically distinct (Louise & Lovinger, 2008; Davis-Cox et al., 1994;
Venance et al., 1998; Wallraff et al., 2004; Zhou et al., 2006; Chai et al., 2017). A
distinction between astrocytic morphology in vitro and in vivo has been recognized
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for many years. Astrocytes cultured in serum-containing media have a flat
polygonal appearance, while astrocytes in vivo possess a classical star-like
morphology with extending filopodia and lamellipodia (Raff et al., 1983; Miller &
Raff, 1984; Lavialle et al., 2011).
In cultured conditions, two astrocytic phenotypes have been distinguished
based on morphological characteristics and regional localization: type 1 cells have
a flat polygonal appearance with a “mesh” of intertwined fine processes and
resemble astrocytes populating grey matter; type II cells have clearly defined
thicker “stellated” processes and resemble the astrocytes arranged along white
matter tracts (Raff et al., 1983; Oberheim et al., 2012). Standard protocols that use
serum-supplemented culture media result in predominantly polygonal, type 1
astrocytes. However, these astrocytes can be transformed into a stellated
morphology by exposure to cAMP analogs (Won and Oh, 2000; Moonen et al.,
1975; Paco et al., 2016). The cAMP-induced morphological transformation occurs
within 2 hours and is associated with decreased cell body area and extension of
distinct thick processes.
In early literature, astroglia in vivo and in vitro have been traditionally
assigned into either of the two phenotypical profiles: protoplasmic of the grey
matter and fibrous of the white matter. However, over the past decade emerging
evidence reveals astrocytes as being a highly heterogeneous neural cell
population. Moreover, this heterogeneity holds important implications for how
astrocytes function within their regions and microenvironments, where astroglia
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are continually interacting with diverse cells in different states in an ever-changing
environment.

1.7

Astrocyte regional heterogeneity
Accumulating evidence demonstrates astrocytes to be a heterogeneous cell

population in vivo and in vitro, across and within brain regions, presenting different
morphologies, genomic profiles, and functions (Louise & Lovinger , 2008; Chai et
al., 2017; Lidellow et al., 2017; Zamanian et al., 2012; Won et al., 200; Miller &
Raff, 1984). In normal conditions, astrocytes display physiological distinctions
between and within the same brain regions (Chai et al., 2017; Hoft et al., 2014;
Miller 2018). In fact, researchers recently investigated differences in hippocampal
and striatal astrocytes in slice and found that while the basic electrical membrane
properties were the same, striatal astrocytes were more susceptible to Kir4.1
blockage in the presence of barium (Ba2+; Chai et al., 2017). In terms of
morphology, unchallenged astrocytes in striatal and hippocampal slices presented
similar forms having the same number of primary processes, as well as equivalent
somatic and total cell volumes (Chai et al., 2017). The extent of astrocytic networks
can be measured by the extent of gap-junction coupling. As with astrocyte density,
studies report differing extents of gap-junction coupling within the striatum with
higher numbers being observed in Louise & Lovinger et al. (2008) and Chai et al.
(2017) than in Hamon et al. 2002 (Hamon et al., 2002; Louise & Lovinger , 2008;
Chai et al., 2017).
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1.8

Astrocyte plasticity and homeostatic control of neurotransmission
As a structurally incorporated component of the synapse, astrocytes

regulate synaptic function and overall brain homeostasis via re-uptake of a variety
of ions, neurotransmitters & neuromodulators, as well as metabolic, trophic, and
plastic factors (Baldwin & Eroglu, 2017; Verkhratsky et al., 2016; Chung et al.,
2015). Astrocytes are also responsible for synaptic pruning, a process which is
crucial in organizing and remodeling synapses to ensure efficient communication
(Chung et al., 2015). Astrocytes are highly connected and can regulate the
neuronal environment and function by altering the concentration of various
essential ions such as potassium (K+) and calcium (Ca2+). In fact, astrocytes form
extensive networks of coupled cells via gap-junctions, and differences in gapjunction gene expression or protein levels often reflect a difference in astrocytic
network architecture and function (Chai et al., 2017; Meunier et al., 2017;
Clasadonte & Haydon, 2014). Astrocytes form this syncytium of cells
interconnected through gap junction channels formed by protein connexin (Louise
& Lovinger , 2008; Dermietzel et al., 1991; Dermietzel et al. 1993). Connexin 43
and connexin 30 connect the cytoplasm of adjacent cells (coupling), and are crucial
for synchronization of astrocytic signaling, calcium wave propagation, and spatial
buffering of potassium (Blomstrand et al., 2005; Cotrina et al., 1998; Giaume &
Venance, 1998; Wallraff et al., 2006). Connexin43 (Gja1) is the major gap-junction
protein connexin of astrocytes, and colocalizes with Connexin30 to couple
astrocytic networks and facilitate intercellular signaling and flow of ions (Lutz et al.,
2009). In fact, double knock-out of connexin 43 and connexin 30 leads to complete
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ablation of astrocytic coupling, with no effects on astrocyte density (Theis et al.,
2003; Wallraff et al., 2006).
Astrocytic gap-junction coupling serves a critical role in extracellular ion
(i.e., Na+, K+, Ca2+) homeostasis, including regulation of potassium (K+) levels.
Moreover, well-established coupling of gap-junctions has been shown to support
“isopotentiality” of astrocytic networks by decreasing the membrane potential
depolarization that follows increased levels of K+, thus regulating the K+ inward
driving force which is necessary for effective astrocytic control of brain
homeostasis (Ma et al., 2016). Importantly, one group of researchers revealed that
astrocytic gap-junctions work to accelerate K+ clearance from the extracellular
space and limit K+ accumulation during synchronized neuronal firing (Wallraff et
al., 2006). Moreover, studies reveal that alterations in astrocytic coupling changes
K+ clearance from the extracellular space which has been linked to alterations in
neuronal function. Specifically, investigators have shown that deficiencies in
astrocytic coupling lead to impaired potassium buffering, a major homeostatic role
of astrocytes, which has been associated with dysfunction of neurons in diseases
such as epilepsy (Ma et al., 2016; Walraff et al., 2006; David et al., 2009).
Astrocytes are also able to modulate neuronal activity and synaptic
transmission through release of certain chemical transmitters, such as glutamate,
ATP, and d-serine in a process called gliotransmission (Haydon 2009, Araque
2014, Koizumi 2003, Fellin 2004, Fellin 2007, Panatier 2006). These transmitters
provide important mechanisms by which neuronal functioning can be regulated.
For example, astrocytic release of ATP facilitates inhibition of excitatory synaptic
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transmission in hippocampal cell populations as evidenced by in vitro and ex vivo
studies (Koizumi 2003, Kang 1998).
Substantial evidence reveals that astrocytes may use Ca2+ transients or
waves as a signaling mechanism for release of various glia-derived molecules
(Santello et al., 2012; Savtchouk & Volterra, 2018; Bazargani & Attwell, 2016).
Furthermore, studies show that dopamine plays a role in modulation of Ca2+
signaling in astrocytes. Specifically, acute application of dopamine or dopamine
receptor agonists, such as SKF83959, to astrocytes in culture has generally been
found to induce elevations in cytosolic Ca2+ via an IP3-mediated release from
intracellular stores (Vaarmann et al., 2010; Parpura & Haydon, 2000; Lee et al.,
2004; Liu et al., 2009; Jennings & Rusakov, 2016; Jennings et al., 2017).
Moreover, investigation of astrocyte calcium dynamics have revealed autonomous
functional domains in this cell population. That is, astrocytic calcium responses
have traditionally been observed in the cell soma; yet, recent evidence shows that
calcium responses can be generated in astrocytic processes that do not propagate
to the soma. Importantly, while astrocytes in general are known to express
neurotransmitters, studies have found that perisynaptic astrocytic processes
(PAPs) also contain neurotransmitter receptors (Algulhon et al., 2008). Activation
of these receptors evokes dynamic Ca2+ transients in astrocytes, which can be
seen from the cell somas to the most distal astrocytic processes (Shigetomi et al.,
2013). Such functionally discrete domains allow for divergent functional
consequences. Depending on the morphology of discrete functional domains, a
single astrocyte could exert different effects on modulation of associated local or
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distant synapses (Covelo and Araque, 2015; Volterra et al., 2014; Shigetomi et al.,
2013).

1.9

Dopaminergic signaling in astrocytes
Cultured astrocytes respond with an increase in cAMP upon application of

dopamine, D1-like receptor agonist SKF38393, and apomorphine, a non-selective
dopamine receptor agonist (Zanassi et al., 1999). These astrocytic responses to
dopamine are region-specific with the largest increase in cAMP occurring in striatal
astrocytes, followed by cortical and cerebellar Bergmann astrocytes. Further,
striatal astrocytes are found to express both dopamine D1 and D2 receptor mRNA
and DRD1 and DRD2 proteins (Hansson et al., 1988; Bal et al., 1994; Zanassi et
al., 1999; Vrana et al., 1995). Gene expression and protein level studies
demonstrate evidence of dopamine receptors D1, D2, D3, D4, and D5 in striatal
and basal ganglia astrocytes (Hansson et al., 1988; Bal et al., 1994; Zanassi et al.,
1999; Miyazaki et al., 2004). These findings provide important physiological
implications in indicating that astrocytes express functional dopamine receptors
which activate intracellular downstream cascades similar to those in neurons.
Dopamine has been found to initiate large intracellular calcium increases in
cultured hippocampal astrocytes (Parpura and Haydon, 2000). Another study
performed in 2001 recognized a cortical population of dopamine D2 receptor
expressing astrocytes in monkey using electron microscopy techniques (Khan et
al., 2001). Further investigation by this group revealed dopamine D2 receptormediated increases in calcium transients in rat and mouse cortical astrocytes. A
more recent study shows that knockout of astrocytic dopamine D2 receptors in
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mice leads to disruption of αβ-crystallin production resulting in systemic
inflammation and marked astrocytic reactivity (Shao et al., 2013). In another study
modeling Parkinson’s Disease, interruption of dopaminergic transmission via
lesioning resulted in a global increase in the astrocytic calcium dynamics
(frequency, amplitude, and duration), as well as an increase in signaling synchrony
and gap junction coupling within the substantia nigra reticulata (SNr) network
(Bosson et al., 2015).
Interestingly, some studies indicate that astrocytes can store and release
dopamine. Astrocytes have been shown to express dopamine transporters in
glioma cells (Russ et al., 1996), in cortical cell cultures (Inazu et al., 1999) and in
striatal tissue (Kittel-Schneider et al., 2012; Inazu et al., 2003). The norepinephrine
transporter has also been identified in cultured cortical astrocytes and may be
responsible for dopamine uptake in these cells (Takeda et al., 2002).
Overall, the literature is explicit in showing that astrocytic morphology may
change in response to environmental stimuli, that astrocytes can express
dopamine receptors, and that dopamine can induce changes in astrocytic signaling
in vitro. However, the consequences of chronically elevated dopamine levels on
astrocytes, as might be observed following exposure to drugs of abuse, are not
clear. Such research would have major implications for understanding astrocyte
function under conditions of elevated dopamine and for elucidating the
physiological role of dopamine-related activity in astrocytic cell populations within
the central nervous system.
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1.10 Astrocyte-synapse relationships
Astrocyte structural plasticity
It is well known that neurons undergo experience-induced functional
remodeling of synaptic elements. These functional alterations in synaptic
transmission serve as the cellular definition of learning, and are associated with
changes in dendritic spine morphology and density believed to be associated with
changes in synaptic strength (Meletic-Salvativ et al., 1999; Toni et al., 1999;
Wilbrect et al., 2010; Perez-Alvarez et al., 2014). The past decade has brought
about increasing interest in understanding structural plasticity of astrocytes and
how this structural plasticity allows for close interplay between/among astrocytes
and neurons (Covelo & Araque, 2018). Astroglia cells in vivo are able to retract or
extend their processes in a plastic manner to make contacts with local synapses,
other astrocytic processes, or blood vessels (Oliet et al., 2001; Oberheim et al.,
2012). Actin-type filaments known as lamellipodia and filopodia composing the
astroglial processes exert a significant influence on synaptic architecture and
physiology (Lavialle et al., 2011; Park et al., 2015; Araque et al., 2014).
Neurotransmitter release by surrounding neurons may exert reciprocal regulatory
action on astrocytes leading to spatial extension and plasticity of astrocytic
processes. For example, oxytocin released during lactation can lead to changes in
astrocyte morphology which can, in turn, blunt release of neurotransmitters (Oliet
et al., 2001). In Parkinson’s Disease plastic changes in astrocyte morphology, such
as upregulation of primary process numbers, increases in individual process
thickness, and extension of processes have been observed to lead to an
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upregulation of astroglial process-to-synapse wrapping and blanketing (Maragakis
& Rothstein, 2006).
Astrocytes maintain close structural relationships with nearby synapses,
physically engulfing or enwrapping synaptic terminals and dendritic spines with
PAPs, an event which can be altered under various physiological conditions
(Haber et al., 2006; Theodosis et al., 2008; Tanaka et al., 2013; Perez-Alvarex et
al., 2014; Bernardinelli et al., 2014). In fact, investigation of astrocytic
ensheathment of synapses via PAPs in various brain regions has revealed
important

functional

implications

for

astrocytic

control

of

excitatory

neurotransmission (Bernardinelli et al., 2014; Lavialle et al., 2011). Specifically,
activation of excitatory synapses through stimulation of metabotropic glutamate
receptors briefly increases motility of PAPs which leads to stabilization of PAPdendritic spine functional and structural interactions (Bernardinelli et al., 2014).
One important actin binding protein localized to PAPs is ezrin, a protein linking the
actin cytoskeleton directly to the plasma membrane (Derouiche & Frotscher, 2001;
Haseleu et al., 2013). Active/open ezrin is exclusively found in PAPs and is
necessary for mGluR3 and mGluR5-mediated motility of astrocytic filopodia
(Lavialle et al., 2011). Specifically, the proximity of PAPs to the synaptic cleft
regulates the expression and functional efficiency of astrocytic transporters, such
as GLT-1 and GLAST, and thus regulates the synaptic environment to modulate
synaptic transmission (Bernardinelli et al., 2014; Lavialle et al., 2011).
Another prominent actin regulator believed to play a role in astrocyte
morphology and PAP formation and motility is gap junction protein connexin 30
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(Gjb6; Pannasch et al., 2014). In the rodent brain, connexin 30 is selectively
expressed in protoplasmic astrocytes and certain pericytes within the brain (Nagy
et al., 1999; Zhang et al., 2014; Mazare et al., 2018). In vitro studies show that
connexin 30 (Gjb6) determines the orientation of astroglial motile protrusions
through modulation of the laminin/β1 integrin/ Cdc42 polarity pathway (Ghezali et
al., 2018). In vivo, ablation of connexin 30 (Gjb6) results in increased ramification
and process length, allowing processes and PAPs to enter the synaptic cleft and
cause elevated uptake of glutamate at excitatory synapses (Pannasch et al.,
2014). While the molecular underpinnings of connexin 30-mediated regulation of
PAPs are still largely unknown, evidence reveals involvement of connexin 30
intracellular C-terminus acting as a hub for interplay with various actin regulators
(Pannasch et al., 2014).
In summary, cellular architectural remodeling, including extension or
ramification of astrocyte primary processes and perisynaptic processes (PAPs),
influences the expression and localization of glutamate transporters (GLT-1 and
GLAST) and gap-junction contacts, connexin 43 (CX43) and connexin 30 (CX30),
which serve as crucial regulators of cell signaling and metabolic homeostasis
among cells in various brain regions. Thus, the nature of how astrocytes interact
or contact synapses to form specialized structural relationships in different brain
regions may have an influence on synaptic function (e.g., strength, plasticity,
efficiency) which underlies changes in behavior.
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Astrocyte functional plasticity at the tripartite synapse
Defined by its functional architecture, and termed the ‘tripartite synapse’,
the relationship between astrocytes and excitatory pre- and postsynaptic neuronal
synapses provides a strong argument for the regulation of synaptic transmission
by astroglial interactions (Figure 1.4; Covelo & Araque 2015, Haydon 2009).
Neuro-glial signaling at the tripartite synapse is reciprocal and supports the
concept of astrocytes acting as integral functional components of the synapses
they are locally associated with. Such association allows for input-specific
regulation of synaptic transmission and plasticity by astrocytes that may serve as
a feedback mechanism (Covelo and Araque, 2015) referred to as lateral astrocyte
synaptic regulation (Rouach et al., 2008; Covelo & Araque 2015).
Glutamate signaling may represent a metabolic correlate of lateral astrocyte
control of synaptic transmission (Covelo and Araque, 2015; Rouach et al., 2008;
Fellin 2004). Specifically, astrocytes have been credited for their role in recycling
glutamate, which exerts an important influence on excitatory and inhibitory
synaptic transmission in regions such as the hippocampus, PFC, and NAc (Fellin
et al., 2004; Fellin et al., 2007; Haydon et al., 2009; Araque 2014; Kang 1998).
Glutamate release from astrocytes occurs through various mechanisms: reverse
action of glutamate transporter (GLT-1), unpaired gap junction pores on cell
surfaces (hemichannels), swelling-induced opening of anion channels, ionotropic
purinergic receptors, Ca2+-dependent vesicular release, and glutamate exchange
via the cysteine-glutamate antiporter (Scofield et al., 2016; Malarkey & Parpura,
2008). Astrocytes spontaneously release glutamate (Glut) as a gliotransmitter and
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astrocytic Ca2+ has been linked to activation of extrasynaptic NMDARs within the
hippocampus (Dong et al., 2013).
Emerging

studies

suggest

these

processes

may

involve

other

neurotransmitter pathways. For example, endocannabinoids released from
pyramidal neurons in the hippocampus can activate astrocyte-bound CB1
receptors leading to a PLC-dependent elevation of astrocytic calcium levels
(Navarette and Araque, 2010). This mobilization of calcium stores stimulates
release of astroglial glutamate which activates NMDA receptors in pyramidal
neurons (Navarette and Araque, 2010). In line with this, work on hippocampal
neuronal and astrocytic cultures also reported that calcium uncaging in astrocytes
as

well

as

mechanical

and/or

electrical

stimulation

trigger

glutamate

gliotransmission that evokes slow inward excitatory currents in adjacent neurons
(Fellin et al., 2004, Haydon et al., 2009, Navarette and Araque 2010, Perea and
Araque, 2005). Furthermore, the threshold for inducing NMDAR-dependent longterm potentiation (LTP) within the hippocampus is lowered when astrocytic
glutamate release accompanies LTP induction, suggesting that astrocytic
glutamate can modulate synaptic plasticity (Park et al., 2015).
Synaptic regulation by astrocytes is not necessarily confined to local active
synapses. Considering the morphological and functional characteristics of
astrocytes, such as long-range propagation of the astrocyte calcium signal (Perea
and Araque, 2005; Di Castro et al., 2011; Panatier et al., 2011), the intercellular
coupling via gap-junctions, and the widespread branching of processes that permit
a single astrocyte to make contact with a multitude of synapses (Bushong et al.,
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2002; Halassa et al., 2007; Lavialle et al., 2011), more spatially extensive
regulatory processes can be conceived. A recent observation was made showing
that genetic suppression of astrocytic IP3-dependent calcium signaling diminishes
astrocytic coverage of hippocampal synapses (Tanaka et al., 2013). Importantly,
the frequency of synaptic activity determines the capability of Ca2+ signals to exert
feedback regulatory mechanisms at local active synapses or apply feedforward
mechanisms at distant synapses (Haydon et al., 2009; Volterra et al., 2014; Araque
et al., 2014; Perea et al., 2014). Thus, under some circumstances, gliotransmission
can act in a highly localized fashion, while other conditions may allow them to act
at more distant sites (Araque et al., 2014; Perea et al., 2014).
Two major astrocyte-secreted factors known to contribute to formation and
specialization of synapses are Hevin (SPACL1) and SPARC. Astrocyte-secreted
SPARC is stimulated by increased glutamate levels which works to reduce the
expression level of synaptic AMPA receptors post-synaptically and promote
specialization of silent synapses (Jones et al., 2011; Kucukdereli et al., 2011; Allen
& Eroglu, 2017). In fact, astrocyte-secreted SPARC and Hevin serve opposite
regulatory roles in synaptic regulation. Treatment of cultured astrocytes with Hevin
triggers re-organization of excitatory synapses in vitro and in vivo. In contrast,
SPARC antagonizes Hevin to prevent synaptogenesis (Singh et al., 2016; Jones
et al., 2011; Kucukdereli et al., 2011; Allen & Eroglu, 2017). In adults, Hevin
expression remains high, while SPARC expression is significantly downregulated
(Morel et al., 2017). The opposing roles of astrocyte-secreted Hevin and SPARC
allow for a homeostatic mechanism to control synaptic excitability, by which the
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astrocyte-neuronal environment regulates synaptic excitability via astrocytemediated processes.

1.11 Alterations in astrocyte-synapse relationships: implications for
substance use disorders
Chronic exposure to drugs of abuse, including cocaine, has been shown to
lead to reactive astrocytosis (Bowers and Kalivas, 2003; Fattore et al., 2002).
Activated astrocytes are characterized by changes in morphology including cell
hypertrophy, increases in individual process thickness, and extension of processes
that is often associated with an expansion of astrocytic coverage of synapses
(Bowers and Kalivas, 2003; Fattore et al., 2002; Maragakis & Rothstein, 2006;
Narita et al., 2006). For example, following 1 and 7 days of repeated cocaine
administration, astrocytes in the mouse dentate gyrus presented marked reactivity
including process thickening and cell body hypertrophy (Fattore et al., 2002). Such
changes in astrocyte morphology following exposure to drugs of abuse are likely
accompanied by changes in astrocytic function. For example, exposure to cocaine
can lead to a reduction in astrocyte morphometric properties which is accompanied
by decrease in extracellular glutamate levels due to impaired activity of astrocytic
cysteine-glutamate and GLT-1 transporters (Baker et al., 2003; Uys and Reissner,
2011; Reissner et al., 2015; Moussawi et al., 2009).
Glutamate gliotransmission has received increasing attention as it has been
associated with the regulation of excitatory synaptic transmission and plasticity in
the striatum and other regions in animal models of substance use disorder
(Scofield et al., 2016; Reeves et al., 2011; Santello et al., 2012; Savtchouk &
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Volterra, 2018). Glutamate transporters are responsible for reuptake of
extracellular glutamate to regulate glutamate concentrations at and around the
synapse. Disruption or insult to these transporters results in glutamate ‘spillover’
from the synapse leading to aberrant excitatory synaptic signaling (Reissner et al.,
2015; Moussawi et al., 2009;) Interestingly, astrocytic glutamate transporters,
GLT-1 and cysteine-glutamate antiporter, have been suggested as potential
therapeutic targets for methamphetamine and cocaine-related neuropathology and
neurotoxicity (Lau et al., 2010; Reissner et al., 2015; Moussawi et al., 2009).
Specifically, studies illustrate diminished levels and activity of astrocytic glutamate
transporters, GLT-1 and cysteine-glutamate system, in the NAc of animals in
withdrawal phase following cocaine self-administration (Reissner et al., 2015;
Moussawi et al., 2009). Moreover, the drug exposure and withdrawal-induced
insults to astrocytic glutamate transporters were associated with higher
susceptibility to reinstatement of drug. Interestingly, via treatment with the
antioxidant, N-acetyl-cysteine, investigators were able to rescue astrocytic
glutamate reuptake systems to regulate excitatory synaptic transmission, as well
as prevent reinstatement of drug (Reissner et al., 2015; Moussawi et al., 2009).
Considering the critical role of glutamate in learning and drug-related behaviors
associated with addiction (Kalivas, 2009; Kalivas and Volkow, 2011; Turner et al.,
2013), neurophysiological consequences of drugs of abuse on astrocytes
represent an important research venue. Identification and characterization of
structural changes that astrocytes undergo in response to drugs of abuse are a
critical step in understanding such consequences.
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Evidence for bidirectional signal transmission from astrocytes to neurons
via gliotransmission reveals a crucial role for astrocytes in their ability to actively
modulate synaptic short- and long-term plasticity (Theodosis et al., 2008; Allen et
al., 2012; Allen, 2014; Hahn et al., 2015; Savtchouk & Volterra, 2018); however,
the responsiveness of individual synapses to alterations in their microenvironment
as well as their vulnerability under pharmacological conditions such as prolonged
cocaine exposure require further investigation.
In disease states, such as substance use disorders, these functional and
structural relationships between astrocytes and neurons are altered to contribute
to the progression of addictive-like behaviors. For example, cue-induced
reinstatement of extinguished cocaine seeking behavior can be inhibited by
mGluR-mediated (mGluR2 and mGluR3) release of glutamate from astrocytes
(Scofield et al., 2015). Cocaine self-administration experience is also
characterized by altered NMDA receptor-dependent synaptic plasticity in the NAc.
In fact, it has been shown that cocaine self-administration in rats increases
activation of extrasynaptic NMDA receptors (Ortinski et al., 2013) that may
influence neuronal excitability in this region. Moreover, it has also been revealed
that cocaine-induced deficits in NMDAR-dependent long-term potentiation (LTP)
and depression result partially from reduced release of D-serine from astrocytes
(Curcio et al., 2013). Administration of D-serine directly into the NAcC in vivo was
able to inhibit behavioral sensitization to cocaine (Curcio et al., 2013). Thus,
glutamate and D-serine appear to represent two major chemical transmitters in
regulation of cocaine sensitization in the ventral striatum.
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1.12 Conclusion
Astrocytes are prevalent throughout the CNS, acting as critical regulators
of overall brain function. Numerous studies over the past two decades collectively
reveal close structural and functional relationships between astrocytes and
neurons. This revelation in recognizing astrocytes as active and dynamic
participants in cell signaling within the brain challenges the idea that experiencedependent changes in neurons define the cellular mechanism of learning and
elevates the idea that astrocytic processes serve crucial roles in plasticity and
learning.
Serving as an integral part of the synapse, astrocytes regulate synaptic
function and overall brain homeostasis via re-uptake and release of a variety of
ions, neurotransmitters & neuromodulators, as well as metabolic, trophic, and
plastic molecules (Baldwin & Eroglu, 2017; Verkhratsky et al., 2016; Chung et al.,
2015). Specifically, astrocytes are able to modulate neuronal activity and synaptic
transmission through release of certain chemical transmitters, such as glutamate
and ATP (Haydonet al., 2009; Araque et al., 2014; Koizumi et al., 2003; Fellin et
al., 2004; Fellin et al., 2007; Panatier et al., 2006). Moreover, astrocytes express
a variety of both metabotropic and ionotropic neurotransmitter receptors, and thus
are sensitive to neurotransmitter action in vitro and in vivo. Thus, these chemical
transmitters provide critical mechanisms by which astrocytes and neurons are
structurally and functionally regulated in both physiological and disease states.
With increasing awareness of the dynamic roles astrocytes play in
regulating neuronal signaling, considerable effort is being placed on investigating
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the potential roles of astrocytes in the regulation of disease states such as drug
addiction. Drug-induced changes in astrocytic profiles are likely to contribute to the
emergence and maintenance of addictive states, as many studies have reported
morphological, functional, and molecular alterations in astrocytes as a result of
drug experience. During the development of drug addiction, drug behavior evolves
from voluntary drug-seeking to compulsive drug-seeking behavior, a behavioral
change associated with a transfer of control over drug-seeking behavior from the
ventral to the dorsal striatum. This ventral-dorsal striatal shift in controI over drug
seeking can be seen as increased DA efflux within the dorsolateral striatum, but
not within the ventral striatum. While several studies have examined the effects of
cocaine self-administration and withdrawal on astrocyte morphometric and
functional properties, the impact of cocaine-induced dopamine fluctuations on
astrocyte plasticity within ventral and dorsal striatum is unknown.
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Figure 1.1. DAR intracellular signaling. Ligand binding to D1-like
receptors stimulates Gαs/olf which dissociate to Gβγ and Gαolf/s-GTP.
Gαolf/s-GTP then stimulates adenylyl cyclase (AC) which increases cyclic
AMP (cAMP). In turn, cAMP activates PKA which goes on to phosphorylate
various targets. D2-like receptors inhibit AC through activation of Gαi/o.
Activation of D2-like receptors inhibits the AC/cAMP/PKA signaling pathway.
Activation of D2-like receptors also results in Gβγ-mediated activation of
PLC resulting in upregulated IP3 production. IP3 promotes release of ER
Ca2+, and the subsequent inactivation of L-type Ca2+ channels and Na+
channels. DRD1s and DRD2s can oligomerize to form heteroreceptors in
certain populations of cells. Ligand binding to D1/D2 heteromers causes a
Gαq-mediated increase in intracellular Ca2+ in a PLC-dependent manner.
Note. Figure reprinted from “Current concepts on the pathophysiological
relevance of dopaminergic receptors,” by A. Ledonne, and N. B. Mercuri,
2017, Front Cell Neurosci, 11, p. 27.
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Figure 1.2. Reward pathways of the CNS. The reward system or dopaminergic
system begins in the VTA, which sends dopaminergic projections to
mesocorticolimbic structures, including the NAc, PFC, and dorsal striatum. The NAc
or ventral striatum receives glutamatergic inputs from PFC, Hipp, thalamus,
amygdala, and VTA, and sends GABAergic projections to regions such as the VP,
VTA, and lateral hypothalamus. Note. Figure reprinted from “Intrinsic plasticity: an
emerging player in addiction,” by S. Kourrich, D. Calu, and A. Bonci, 2015, Nature
Rev Neurosci, 16(3), p. 173 - 184. Copyright (2015), with permission to reprint from
Springer Nature.
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Figure 1.3. Direct & indirect pathways for movement. Direct pathway MSNs (dMSNs)
express D1-like receptors. Activation of dMSNs promotes motivated behavior. Indirect pathway
MSNs (iMSNs) express D2-like receptors. Activation of dMSNs inhibits motivated behavior or
unwanted movement. * Nigrostriatal dopamine is particularly relevant during stereotyped
(repetitive) motor behavior prominent with high doses of psychostimulants.
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Figure 1.4. The tripartite synapse. Schematic showing a presynaptic (Pre) and
postsynaptic (Post) terminal enwrapped by the astrocytic process (green) forming
the tripartite synapse. High structural interplay of astrocytic process(es) with
presynaptic and postsynaptic terminals exerts crucial roles including clearing of
neuronal activity-induced accumulation of K+ ions and uptake of glutamate by
glutamate transporters (i.e., Xc-, GLT-1, GLAST). Neurotransmitter release from
presynaptic terminals can activate astrocytic mGluRs, which induce IP3dependent release of Ca2+ from internal stores, which in turn triggers the release
of several gliotransmitters. Schematic adapted from Halassa et al., 2007.

CHAPTER 2
METHODS
2.1

In vitro model of elevated extracellular dopamine
Primary astrocytes were dissociated from hippocampi of neonatal

(postnatal day 1-2) Sprague-Dawley rat pups. The heads were removed and
hippocampi dissected in Petri dishes filled with ice-cold dissection medium
composed of: Hank’s Balanced Salt Solution (without Ca2+, Mg2+, NaHCO3, or
phenol red) supplemented with 10 mM HEPES (both from Sigma). The dissected
hippocampi were finely chopped and dissociated by trypsin treatment (10 µl/mL;
Gibco), followed by trituration with sterile glass pipettes. Cells were plated on 12
mm glass coverslips, 6-well, or 24-well plates coated with poly-l-lysine (50 µg/mL;
Sigma). Cultures were maintained in DMEM/F12 (Gibco) media supplemented
with 10% fetal bovine serum (FBS) and stored in an incubator at 37ºC (5% O2/95%
CO2) for 10-14 days (DIV 10-14). This protocol produces astrocyte-enriched
cultures with majority of all cells staining positive for the astrocyte marker, glial
fibrillary acidic protein (GFAP). Cultured cell groups were subsequently selected
and treated with dopamine (0.1, 1, 10, & 75 µM) or vehicle before being harvested
for immunocytochemistry or qRT-PCR.

Galloway, A. G.*, Adeluyi, A. A.*, O’Donovan, B., Fisher, M. L., Rao, C. N…. & Ortinski,
P. I. (2018). Dopamine triggers CTCF-dependent morphological and genomic
remodeling of astrocytes. Journal of Neuroscience. Reprinted here with permission from
publisher. * indicates equal contributions
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2.2

Intravenous catheter implantation for cocaine self-administration
Under isoflurane anesthesia (2-5% isoflurane in O2) an indwelling silastic

catheter (SAI infusion technologies, Lake Villa, IL, USA) was placed into the right
jugular vein and sutured in place. The catheter was routed to a mesh backmount
platform that was implanted subcutaneously dorsal to the shoulder blades.
Catheters were flushed daily with 0.3 ml of antibiotic (Timentin, 0.93 mg/ml)
dissolved in heparinized saline and sealed with plastic obturators when not in use.
After surgery, rats were allowed 7 days to recover before behavioral testing
commenced.
Animals and housing
Male Sprague-Dawley rats (Rattus norvegicus) weighing 250–275 g were
obtained from Taconic Laboratories. Animals were individually housed and kept
on a 12/12 HR light/dark cycle with the lights on at 7:00 a.m. All experimental
procedures were performed during the light cycle. During the weeks of cocaine
self-administration, rats were limited to 30 g of food per day (and water ad libitum)
to minimize the effect of motivational differences due to natural variations in food
intake and weight gain across rats. The experimental protocols were all consistent
with the guidelines issued by the U.S. National Institutes of Health and were
approved by the University of South Carolina School of Medicine’s Institutional
Animal Care and Use Committee. Food and water were available ad libitum in their
home cages.
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2.3

Animal model of elevated extracellular dopamine signaling
The study utilizes a rat behavioral regime of cocaine self-administration

under a short- or extended-access protocol (based on Wilhuhn et al., 2012) to
determine the impact of cocaine duration on astrocytes in the dorsal and ventral
striatum. Specifically, this project aimed to observe sub-region and experiencedependent changes in astrocytes associated with physiological shifts in
dopaminergic signaling in the NAcC and dorsolateral striatum of cocaineexperienced animals.
Operant Conditioning for Cocaine Self-Administration
Each rat trained to respond for contingent cocaine infusions was paired with
a yoked subject that received infusions of saline (Figure 2.1). Lever pressing for
the saline‐yoked rats had no scheduled consequences, but these animals received
the same number and temporal pattern of infusions as self‐administered by the
paired cocaine‐experimental rat. Cocaine-experimental rats were allowed to self‐
administer cocaine for 7 (short-access) or 21 days (extended access). Rats were
allowed to self-administer a maximum of 40 injections per 60 minutes/daily operant
session. Each operant session began with the intravenous administration of 59 μl
cocaine (0.25 mg) to fill the catheter. Rats were placed in operant chambers and
allowed to lever-press for intravenous infusions of cocaine (0.25 mg cocaine/59 μl
saline, infused over a 5 s period) on a fixed-ratio 1 (FR1) schedule of reinforcement
during which one lever press (with light cue present) results in a single infusion of
cocaine. A 20 s time-out period followed each cocaine infusion, during which time
active lever responses were recorded, but had no scheduled consequences.
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Responses made on the inactive lever, which had no scheduled consequences,
were also recorded during training sessions. Rats were decapitated following
isoflurane anesthesia the day after the last drug operant session.

2.4

Immunocytochemistry and immunohistochemistry
Immunocytochemical and immunohistochemical techniques allow for the

visualization of proteins, peptides and enzymes of interest using the basic
properties of antibody/antigen binding interactions. Immunocytochemistry was
used to assess dopamine effects on astrocyte morphology in vitro and
immunohistochemistry was utilized to assess dopamine-associated alterations in
astrocytes in vivo within the striatum using the following protocols:
Immunocytochemistry
Following 10-12 DIV, primary cultured cells plated on sterile glass 12mm
coverslips were washed twice in PBS at room temperature (pH 7.4, RT), fixed in
4% paraformaldehyde (PFA; 10 – 20 minutes at 37°C; Affymetrix), and then
washed with 1XPBS three times. The cells were next treated with 0.3% Triton-X
(Sigma) for 15 minutes and washed once with 1XPBS. Nonspecific staining was
blocked with PBS containing 0.1% tween 20 (Thermo-Fisher) and 10% donkey or
goat serum (Sigma) for 1 – 2 hours at room temperature (RT). Coverslips were
incubated with primary (mouse, polyclonal) antibodies against GFAP (1:1000; 2
HR, RT; Millipore Sigma; MAB360), and then washed with 1XPBS three times. For
characterization of culture cell type content, coverslips were incubated with primary
antibodies against Olig1, CD11b, or NeuN and GFAP (Refer to Table 2.2) before
being washed in 1X PBS three times. Fluorescent staining was then carried out by
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incubating with secondary antibodies (1:1000; Life Technologies) conjugated to
AlexaFluor 488 (A11008) or AlexaFluor594 (A21203) at RT in the dark for 1 HR.
Cells were then washed three times with 1XPBS and counter-stained with DAPI (5
µg/mL; Molecular Probes) for 5 minutes. Finally, coverslips were rinsed once with
distilled H2O and mounted on glass slides with Prolong Antifade mounting medium
(Life Technologies). Negative controls omitting primary or secondary antibodies
were included in all experiments. All washes were carried out with 1XPBS (pH 7.4)
at RT.
Immunohistochemistry
Whole brains were removed and fixed for 48hrs in 1XPBS (0.1 M)
containing 4% paraformaldehyde at 4°C prior to being transferred to a 1XPBS
containing 30% sucrose and stored at 4°C. When brains were sufficiently
equilibrated, striatal regions were coronally sectioned at 35 µm thickness using a
Vibratome (Vibratome information). Free-floating sections were collected in cold
(4°C) 1XPBS for immunohistochemical processing.
Free floating tissue sections were transferred to fresh 1XPBS (RT) and
rinsed with 1XPBS three times. Sections were next treated with 1XPBS (Life
Technologies) containing 0.3% Triton-X (Sigma) for 20 minutes and washed once
with 1XPBS. Nonspecific staining was blocked with 1XPBS containing 0.1% tween
20 (Thermo-Fisher) and 10% donkey or goat serum (Sigma) for 1 – 2 hours at
room temperature (RT). Sections were incubated with a 1XPBS solution containing
2% goat serum (Sigma), .1% Triton-X (Sigma), and primary (rabbit, polyclonal)
antibody against GFAP (1:500; 48 HR at 4°C; Abcam; ab7260), and then washed
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with 1XPBS four times. Fluorescent staining was then carried out by incubating
with

secondary

antibodies

(1:1000;

Life

Technologies)

conjugated

to

AlexaFluor647 (A21245) at RT in the dark for 2 HR. Sections were then rinsed four
times with 1XPBS and counter-stained with DAPI (5 µg/mL; Molecular Probes) for
5-10 minutes. Finally, sections were rinsed once with 1X PBS and mounted on
glass slides with Prolong Antifade mounting medium (Life Technologies). Negative
controls omitting primary or secondary antibodies were included in all experiments.
All washes were carried out with 1XPBS (pH 7.4) at RT.

2.5

Immunofluorescent imaging and analysis: density and morphology

Analyses of cultured astrocytes
Cells were examined under a widefield fluorescent microscope (Eclipse
E200, Nikon). To determine the effect of exogenous dopamine on astrocyte
morphology, morphometric analyses were conducted with NIH ImageJ software.
(Figure 2.2a) For cell area measurements, GFAP-positive cells were manually
outlined and isolated from background by applying a color threshold. For analysis
of stellation, all distinct primary processes extending directly from the cell body,
thinner than 40 pixels wide, and at least 30 pixels in length were counted (Figure
2.2b).
Analyses of astrocytes in slice
For slice imaging, mounted sections of rat striatum stained for GFAP (Alexa
Fluor 647) were imaged using a Leica SP8 Multiphoton confocal microscope
(Germany). Image stacks (Δz, .35 µm) of striatal sections were collected using a
63x oil objective with 638 nm diode and MP lasers. To evaluate the effect of
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cocaine self- administration on astrocyte density and morphology, cell count and
morphometric analyses were carried out using Leica SP8 3D analysis software.
For density measures, individual z-stacks were rendered in 3D and GFAP+ cells
depicting whole astrocytes were manually selected, counted, and reported as
number of GFAP+ cells/field. For individual cell morphometric analysis, GFAP+
cells were manually selected, individually thresholded, and then isolated for
measurements of cell surface area and volume and manual measurement of
primary process length & count (Figure 2.3a). For analysis of stellation, all distinct
primary process extending directly from the cell body were counted (Figure
2.3b,c). All objects on the edge of image field were occluded.

2.6

Western blot procedure and analysis of primary cultured astrocytes
Cultured cells were gently washed in 1XPBS before being gently scraped

and collected. Cells were homogenized in 200 μL of ice-cold extraction buffer
containing 50 mM Tris, 1 mM EGTA, 1 mM EDTA, 1% SDS, and 1 mM PMSF (pH
7.4). Protein concentrations were determined using a BCA assay, with bovine
serum albumin as the standard. Prior to loading, 6x SDS Sample buffer (50 mM
Tris, 2.5% SDS, 36% glycerol, 0.03% bromophenol blue and 1M DTT) was added
to each sample, which were then boiled for 5 minutes. Equivalent amounts of
protein (30 μg) for each sample were resolved in 10% SDS-PAGE. After
electrophoresis,

proteins

were

transferred

to

nitrocellulose

membranes.

Membranes were incubated with LI-COR blocking buffer (LI-COR, Lincoln, NE) for
1 HR at room temperature to block non-specific binding. The blots were reacted
overnight at 4°C with primary antibodies Acetyl-α-tubulin (1:1000, Lys40; Cell
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Signaling Technology, Lake Placid, NY) rabbit mAb and α-tubulin (1:1000, acetyl
K40; Abcam, Cambridge, MA) mouse mAB or, Acetylated-Lysine (1:1000, Cell
Signaling Technology, Lake Placid, NY) rabbit pAB and alpha-tubulin (1:2000,
Abcam, Cambridge, MA) mouse mAB. After washing in PBS-T, the blots were
incubated in fluorescent secondary antibodies (1:20,000, LI-COR, Lincoln, NE) in
LI-COR blocking buffer for 1 HR at RT. Membranes were then washed three times
with PBS-T. Immunolabeling detection and densitometry measurements were
performed using the LI-COR Odyssey System (LI-COR, Lincoln, NE). The blots
were stripped using LI-COR Newblot stripping buffer (5x) (LI-COR, Lincoln, NE),
washed, and re-probed with antibodies for acetylated alpha tubulin or acetylated
lysine (1:1000, Cell Signaling Technology, Lake Placid, NY) and the reference
antibody (β-tubulin). Blots were re-scanned following stripping to ensure complete
removal of signal. Ratios of acetylated alpha tubulin or total acetylated lysine to βtubulin densities were calculated for each sample and analyzed across conditions.

2.7

Genetic characterization: RNA sequencing and RT-QPCR

RNA Extraction / Sequencing
Total RNA was extracted using TRIzol (Life Technologies) and a RNeasy
Mini Kit (Qiagen) according to manufacturers’ instructions. Samples were
homogenized and incubated in TRIzol for 5 minutes before addition of chloroform
and brief vigorous shaking for 30 seconds. Following a 3 minute incubation,
samples were centrifuged at 4°C for 10 minutes at maximum speed (≥10,000rpm).
The aqueous phase was aspirated and transferred to a microcentrifuge tube before
addition of 70% EtOH, centrifugation at ≥10,000 rpm for 15 seconds and collection
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of the precipitate from the RNeasy mini column. This step was repeated after
adding 700 µL Buffer RW1 and next 500 µL Buffer RPE to the mini column. Another
500 µL of Buffer RPE was centrifuged for 2 minutes before the sample/mini column
underwent a 2 minute “dry” spin and transferred to the final collection tube. Last,
30 µL DEPC water was used to elute the sample. RNA samples were quantified
using NanoDrop Spectrophotometer ND-2000 (Nanodrop Technologies) and
checked for quality and degradation by Agilent 2100 Bioanalyzer. All samples were
of high quality (RNA integrity number (RIN) between 9.9 and 10). Strand-specific
mRNA libraries were prepared using the TruSeq Stranded mRNA Library Prep Kit
(Set B, Illumina Inc.) and sequenced on the Illumina NextSeq500 in a paired-end
mode with read length of 2 x 75bp.
Sequencing data preprocessing and analyses
To ensure there were no sequencing errors, raw sequences were checked
for quality using FastQC, and then aligned to the rat genome (downloaded from
iGenomes, Illumina) using the STAR aligner program (Dobin et al., 2013). Aligned
SAM files from STAR were converted to BAM files using SAMtools (Li et al., 2009).
BAM files were processed for read summarization using feature counts (Liao et
al., 2014), and the resulting read counts were preprocessed by filtering out low
read counts (read counts < 5) in R software. Processed data were then analyzed
for differential expression using DESeq2 (Love et al., 2014) in R software. False
discovery rate (FDR < 0.05) was used to determine the threshold of p-value for the
analysis.
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Functional annotation/gene ontology analyses for biological function were
conducted using Panther classification system (www.pantherdb.org) accessed in
September-October, 2017. CTCF binding motif analysis was performed using
CTCFBSDB 2.0 (Ziebarth et al., 2013), a database for CTCF binding sites and
genome organization. Top 30 differentially expressed genes (15 downregulated
and 15 upregulated) from each of the treatment groups were extracted, and then
matched with the downloaded CTCF binding motif database. This analysis was
completed in R software.
RT-qPCR
Oligonucleotide primers were designed using the NCBI Primer-Designing
tool, checked for specificity via the BLAST database, and supplied by Eurofins
Genomics (Table 2.3). The following primers were used in our in vitro experiments:
FosB, PDE10A, AP1S3, GPR83, Nr4a3, Klf4. For each primer tested, 1000 µL of
primer mix contained: 200 µL of 100 µM forward primer, 200 µL of 100 µM reverse
primer, and 600 µL of DEPC H2O. Samples were diluted to 500 ng/µL with DEPC
water before undergoing cDNA synthesis. For each sample, 10 µL of 2X SYBR
Green Mix (Applied Biosystems, ThermoFisherScientific), 4 µL of DEPC H2O, and
1 µl of cDNA sample was prepared and subsequently mixed with 5 µL of primer
mix for a total volume of 20 µl before pipetting into a 385-well plate. Real-time PCR
was carried out using Bio-Rad CFX384 Real-Time PCR Detection System. For all
genes, the cycling parameters were as follows: initial denaturation at 95 ºC for 3
minutes, 40 cycles of 95 ºC for 20 s, and final cycle of 60 ºC for 20 s. Transcript
measurements in each sample were done in triplicates. The mRNA levels were
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determined using the 2-ΔΔCT method (Livak and Schmittgen, 2001) and target
genes were normalized to the housekeeping genes Glyceraldehyde-3-phosphate
Dehydrogenase (GAPDH) or Hypoxanthine Phosphoribosyltransferase (HPRT).
Expression values were normalized to GAPDH and reported as a fold change.

2.8

Calcium imaging of cultured astrocytes
Astrocyte cultures were incubated with 5 μL of GFAP-driven GCamp6f virus

(AAV5.GfaABC1D.cytoGCamp6f.SV50, Addgene #52925, packaged by the
University of Pennsylvania Vector Core) for 3 – 5 days prior to imaging at DIV 10
– 14. Coverslips were transferred to a recording chamber continuously perfused
(2 – 3 ml/minute) with recording solution composed of (in mM): 145 NaCl, 5 KCl, 1
MgCl2, 1 CaCl2, 5 HEPES, 5 glucose, and 15 sucrose (all from Sigma) adjusted to
pH 7.4 with NaOH. Two-minute videos were acquired with ORCA-Flash 4.0 (V2)
digital camera mounted on an Olympus BX51WI upright microscope equipped with
an LED light source (X-Cite XLED1, Excelitas Technologies). Videos were binned
at 1024 x 1024 pixels and collected at 25 frames/second. Background subtraction
and fluorescent signal measurements were done using ImageJ based on manual
isolation of individual cells as regions of interests (ROIs). Relative fluorescence
intensity within each ROI was calculated as dF/F0, where F0 is average
fluorescence intensity in a one second window of baseline fluorescence for each
ROI identified in a background-subtracted image. Average amplitude and duration
of Ca2+ transients exceeding three standard deviations of baseline noise were
calculated following manually curated identification of individual events in Clampfit
10.4 (Molecular Devices). Ca2+ transient duration was expressed for each cell as
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half-width – the time between two frames on either side of the peak that are first to
reach 50% of peak amplitude relative to baseline. Event frequency for each cell
was calculated as total number of identified events per two-minute video.

2.9

Electrophysiology of cultured astrocytes
Coverslip-plated astrocytes were viewed in a perfusion chamber under an

upright microscope (Olympus BX51WI) with infrared differential interference
contrast optics and a 40× water-immersion objective. Recording solution was the
same as described for Ca2+ imaging. Recording pipettes were pulled from
borosilicate glass capillaries (World Precision Instruments) to a resistance of 4–7
MΩ when filled with the intracellular solution. The intracellular solution contained
the following (in mM): 145 potassium gluconate, 2 MgCl2, 2.5 KCl, 2.5 NaCl, 0.1
BAPTA, 10 HEPES, 2 Mg-ATP, and 0.5 GTP-Tris, adjusted to pH 7.2–7.3 with
KOH, osmolarity 280–290 mOsm. Currents were low-pass filtered at 2 kHz and
digitized at 20 kHz using Digidata 1440A acquisition board (Molecular Devices)
and pClamp10 software (Molecular Devices). Potassium (K+) currents were
recorded in voltage-clamp mode (Vholding=-80 mV). Access resistance (10–30 MΩ)
was monitored throughout each recording by injection of 10 mV hyperpolarizing
pulses; data were discarded if access resistance changed >25% over the course
of data collection. Following seal rupture, series resistance was compensated (6575%). Inward rectifying K+ currents were evoked by a series of 10 mV, 40 ms-long
steps from -180 mV to -80 mV following a 200 ms pre-step to 0 mV. Outward K+
currents were evoked by a series of 10 mV, 500 ms-long voltage steps from -80
mV to +80 mV following a 100 ms pre-step to -110 mV or -50 mV. Outward delayed
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rectifier K+ currents were measured following pre-steps to -50 mV. Outward A-type
K+ currents were isolated by subtracting traces recorded following pre-steps to -50
mV from those recorded following pre-steps to -110 mV. Inward rectifying K+
currents were measured at the end of the 40 ms step. Delayed rectifier and A-type
K+ currents were measured at current peak. All measurements were acquired
using Clampfit 10 (Molecular Devices).

2.10 Statistical analysis
Statistical analyses were performed with Excel 2016 (Microsoft) or
GraphPad Prism 6 (GraphPad Software). For immunocytochemical, Ca2+ imaging,
and electrophysiological experiments, cells from a minimum of 3 different
coverslips were analyzed for each reported condition. For immunohistochemistry,
fields from 3 different animals per experimental group were analyzed for density
measures. For individual analyses of GFAP+ cell morphometric properties, 3 cells
were randomly selected from 3D-rendered z-stacks formerly used to obtain GFAP+
density measures. One-way analysis of variance (ANOVA) with Bonferroni post
hoc tests were used for morphological analyses of

GFAP+ cells in

immunocytochemical and immunohistochemical experiments. Due to the low size
(n = 2 fields, 3 cells), ordinary two-way ANOVAs were not utilized in ex vivo
analyses of GFAP+ density and morphology. Immunofluorescent morphological
measurements

for

cultured

cells

were

made

using

ImageJ

Fiji

and

immunofluorescent density and morphological measurements for GFAP + cells in
slice were obtained using Leica SP8 3D Analysis software. For RNA sequencing
(RNA-seq), cells from 3-4 experimental replicates were processed for analysis as
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described above. For qPCR validation of RNA-seq data, one-way ANOVAs were
utilized for each gene. In the hippocampal and striatal slice experiments, planned
comparisons predicted effects of dopamine and/or dopamine antagonists
compared to control condition, thus Student’s t-tests were performed to determine
significance. For qPCR assessment of mRNA expression in cocaine-experienced
animals and yoked saline controls, 5-6 biological replicates were used for each of
the 6 genes and unpaired two-tailed Student’s t-test were utilized to determine
significance. For electrophysiological studies, mean peak K+ current amplitude
was analyzed with two-way repeated measures ANOVAs with current amplitude
as a within-subject factor and drug treatment as a between subject factor followed
by Bonferroni post hoc tests. For western blot experiment, band intensity was
measured and ratios of acetylated alpha tubulin or total acetylated lysine to βtubulin densities were calculated for each sample and analyzed across conditions.
Significance was determined using two-way ANOVA. One-way analysis of
variance (ANOVA) or two-way ANOVA with Bonferroni’s multiple comparison tests,
or unpaired two-tailed Student’s t-test were used as indicated in results or figure
legends. Data were reported as mean ± standard error of the mean and
significance threshold was set at p<0.05.
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Figure 2.1. Cocaine self-administration. (A) Depiction of a rat connected with indwelling
catheter (red arrow) for i.v. delivery of cocaine in the operant chamber. (B) An active lever press
(blue arrow, dashed line) elicits an infusion of cocaine (0.5 mg/kg per infusion) over 5 s followed
by a 20 s time-out (house light on top is off).
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Figure 2.2. Analysis of astrocyte morphology in vitro. (A) Example of GFAP-positive cell area measurements.
We first isolated cell to eliminate noise and cell interference and applied a color threshold to the isolated cell prior
to selecting the measure function. Scale bars, 100 pixels, 50 pixels. (B) Example of process length measurement.
Scale bar, 50 pixels.
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Figure 2.3. Analysis of astrocyte morphology ex vivo. (A) Example of striatal slice stained for GFAP (red).
Scale bar, 15 µm. (B) Isolate cell (aqua) by applying threshold. Scale bar, 5 µm. (C) Example of manual
process length measurement and process count (magenta). Scale bars, 5 µm.

Table 2.1
Summary of antibodies used in immunocytochemical and
immunohistochemical assays

Table 2.2

Summary of oligo primer sequences used in qRT-PCR
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CHAPTER 3
EFFECTS OF ELEVATED EXTRACELLULAR DOPAMINE
EXPOSURE ON ASTROCYTES IN VITRO
3.1

Introduction
To date, there have not been any published studies which report on the

morphological and/or phenotypical effects of dopamine in astrocytes. Yet, studies
highlight dopamine potential in inducing functional alterations through astrocytebound dopamine receptors which may translate to changes in astrocytic
morphological and phenotypical profile. My results provide evidence that
exogenous application of dopamine can trigger morphological and phenotypic
alterations in primary cultured hippocampal astrocytes which may have
implications for astrocytic function.
Astrocytes are a major subpopulation of the brain glial cells that mediate
multiple functions, including metabolic, ionic and pH homeostasis, trophic support
of neurons, antioxidant defense, the establishment and maintenance of the blood
brain barrier, and regulation of neuronal activity (Kandel et al., 2012; Oberheim et
al., 2012; Fattore et al., 2002; Clark et al., 2013; Zamanian et al., 2012; Clark and
Galloway, A. G.*, Adeluyi, A. A.*, O’Donovan, B., Fisher, M. L., Rao, C. N…. & Ortinski,
P. I. (2018). Dopamine triggers CTCF-dependent morphological and genomic
remodeling of astrocytes. Journal of Neuroscience. Reprinted here with permission from
publisher. * indicates equal contributions

52

Barres, 2013; Freeman et al., 2010; Bushong et al., 2002; Perea et al., 2009). Such
functional diversity is accompanied by morphological heterogeneity that varies with
development and across brain regions (Raff et al., 1983; Miller and Raff, 1984;
Khakh and Sofroniew, 2015; Chai et al., 2017). For example, astrocytic domain
boundaries are observed later, but not early in development (Bushong et al., 2004)
and astrocytes in the striatum have significantly more processes than hippocampal
astrocytes (Chai et al., 2017; Khakh and Sofroniew, 2015).
In cultured conditions, two astrocytic phenotypes have been distinguished
based on morphological characteristics: type I cells have a flat polygonal
appearance with a “mesh” of intertwined fine processes and resemble astrocytes
populating grey matter; type II cells have clearly defined thicker “stellated”
processes and resemble the astrocytes arranged along white matter tracts (Raff
et al., 1983; Oberheim et al., 2012). Standard protocols that use serumsupplemented culture media result in predominantly polygonal, type I astrocytes.
However, these astrocytes can be transformed into a stellated morphology by
exposure to cAMP analogs (Won and Oh, 2000; Moonen et al., 1975; Paco et al.,
2016). The cAMP-induced morphological transformation occurs within 2 hours and
is associated with decreased cell body area and extension of distinct thick
processes.
Dopamine may trigger cAMP production via activation of D1-like dopamine
receptors, expressed by astrocytes along with other dopamine receptor subtypes
(Miyazaki et al., 2004; Shao et al., 2013; Mladinov et al., 2010; Khan et al., 2001;
Nagatomo et al. 2017). D1-induced production of cAMP has been linked to release
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of astrocytic Ca2+ from internal stores, an important hallmark of astrocyte-toastrocyte, astrocyte-to-neuron, and astrocyte-to-vasculature signaling (Jennings et
al., 2017; Chai et al., 2017). Indeed, both structural and functional astrocyte
adaptations have been reported in models of neurologic disease linked to
dysregulated dopamine signaling. For example, Parkinson’s disease is associated
with hypertrophy of astrocytic processes, a feature of reactive astrocytosis (Booth
et al., 2017), while cocaine use has been linked to a reduction of astrocyte surface
area and reduced interaction with synapses (Scofield et al., 2016). Furthermore, a
number of studies have demonstrated that dopamine-induced increase in
astrocytic Ca2+ impacts cellular respiration mechanisms coupled to PARP1 and
sirtuin activation (Requardt et al., 2010; Requardt et al., 2012; Gupte et al., 2017;
Verdin, 2015). PARP1 is a critical co-factor for NAD+-dependent poly-ADPribosylation of CCCTC binding factor (CTCF) which promotes CTCF binding to
target genes (Yu et al., 2004; Ong et al., 2013; Han et al., 2017). Recent studies
have shown that CTCF regulates both chromatin remodeling (Wright et al., 2016)
and chromatin insulation (Yu et al., 2004, Ong et al., 2013), thereby organizing
transcriptional regulation of distinct gene suites in response to cellular signaling.
However, it is unknown whether dopamine- or dopamine receptor-induced
structural or genomic changes are linked to PARP1/CTCF interaction.
This study demonstrates that dopamine receptor signaling generates
pronounced morphological changes in cultured astrocytes which rely on PARP1
activation and are accompanied by a dynamic regulation of the astrocyte
transcriptome including, most prominently, specific enrichment of genes containing
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CTCF motifs in promoter regions. Our results highlight a novel PARP1/CTCFdependent mechanism that drives dopamine-induced morphological changes and
associated transcriptional profile in astrocytes.

3.2

Characterization of primary cultures
To characterize primary culture cell-type content, this study first utilized

fluorescent immunocytochemical assays to assess microglial, neuronal, and
astrocyte content in untreated cells. Thus, primary cultures were evaluated for
contaminating cell types via immunocytochemical assays using antibodies against
CD11B (microglia), NeuN (neurons), and GFAP (astrocytes), as well as a nuclear
counterstain, DAPI (Figure 3.1). Notably, the neuronal presence is negligible in
these cultures and the microglial presence is similar to that seen in previous
studies (Saura, 2007). Therefore, culture conditions in this study result in GFAPpositive, astroglia enriched cell population.

3.3

Elevated dopamine leads to stellation of astrocyte processes in vitro
To examine effects of dopamine on astrocyte morphology, cultured cells

underwent GFAP immunostaining following treatment with dopamine (75 μM) for
1, 24, and 48 hours. This revealed a rapid and persistent dopamine-induced
stellation (Figure 3.2). Following 1 HR of exposure, dopamine induced a 3.2-fold
increase in the number of primary processes and also significantly reduced mean
GFAP-positive (GFAP+) cell area to 81±5.6% of control values (Figure 3.2). The
increase in process number was maintained following 24 and 48 hours of treatment
(253±23.8% and 266±16.8%, respectively). However, reduction in GFAP+ area
recovered to control levels by the 48-hour timepoint. Astrocytes exposed to control
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media for 1, 24, or 48 hours had similar stellation and GFAP + area and were pooled
together for analysis (Figure 3.2).
This project also examined astrocyte response to dopamine concentrations
in the low nanomolar to low micromolar range, similar to the reported brain
dopamine levels (Smith et al., 1992; Zhang et al., 2009). Process number was
significantly increased to 169±12.6% of control values following a one-hour
treatment with the lowest dopamine concentration (0.1 µM) and continued to
increase at a more modest rate following treatments with 1, 10, and 75 µM
dopamine (196±15.9%, 219±19.9%, and 236±17.6% of control values,
respectively; Figure 3.3). Interestingly, the decrease in GFAP+ area was strongest
after a one-hour treatment with 0.1 and 1 µM dopamine (62.4±4.4% and
62.9±5.1% of control values, respectively), but failed to reach statistical
significance after treatment with 10 µM or 75 µM dopamine in this experiment
(73.5±10.6% and 82.9±6.2% of control values, respectively; Figure 3.3). These
results indicated that exposure to elevated dopamine triggered a rapid,
pronounced, and sustained concentration-dependent stellation of astrocyte
processes. Dopamine-induced reduction in GFAP+ area was more variable
between cultures and had a distinctly different concentration-dependence profile.

3.4

Astrocyte stellation is mediated by dopamine receptors
Dopamine can undergo oxidation in cell culture media and oxidative

processes have been linked to changes in astrocyte morphology, including
stellation (Clement et al., 2002; Pekny and Nilsson, 2005; Sofroniew, 2009;
Vaarmann et al., 2010). Sodium metabisulfite (SMBS) and N-acetyl-L-cysteine
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(NAC) can be used to prevent oxidation of dopamine (Goldstein et al., 2017;
Ortinski et al., 2015). To examine whether oxidative processes play a role in
dopamine-induced astrocyte stellation, we pre-treated the astrocyte cultures with
NAC (5 mM) in culture media for 15 minutes prior to addition of dopamine (75 µM)
for one hour. This treatment did not prevent stellation of astrocyte processes. We
observed an average of 236±17.6% increase in number of processes for cells
treated with dopamine alone versus an average increase of 285±29.6% in number
of processes for cells treated with dopamine and NAC (Figure 3.4). GFAP+ cell
area was reduced following NAC pre-treatment (42±4.5% of control levels) in
excess of what was observed with dopamine alone (82.9±6.2% of control levels).
This suggests that, in the absence of NAC, dopamine oxidation or background
oxidative processes may oppose dopamine-induced effects on GFAP+ area. Pretreatment with SMBS (50 µM), a different antioxidant, had similar effects: SMBS
failed to prevent dopamine-induced stellation, but did facilitate reduction of GFAP+
area (Figure 3.4).
To test whether dopamine-induced stellation required activation of
dopamine receptors, we examined the effects of pre-treatment with the D1-like
dopamine receptor antagonist, SCH23390 (50 µM), or the D2-like dopamine
receptor antagonist, sulpiride (20 µM). Cells were pre-treated with one or both
antagonists for 15 minutes prior to addition of dopamine (75 µM) for one hour. The
results indicated that dopamine-induced stellation could be blunted by either D1like or D2-like dopamine receptor antagonists. Pre-treatment with SCH23390
rescued a 257±15.7% dopamine-induced increase in process number to
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145±13.6% of control levels, whereas pre-treatment with sulpiride rescued
dopamine-induced increase in process number to 166±14% of control levels
(Figure 3.5). Pre-treatment with both SCH23390 and sulpiride, surprisingly, was
less effective in blunting dopamine-induced stellation (193±21.2% of control
values) than treatment with either antagonist plus dopamine. We also investigated
the possibility that dopamine could drive stellation through the Gq-PLC pathwaycoupled D1/D2 heterooligomers (Beaulieu and Gainetdinov, 2011). A 15-minute
pre-incubation

with

the

membrane-permeable

IP3

inhibitor,

2-

Aminoethoxydiphenylborane (2-APB; 50 µM), prior to the one-hour treatment with
dopamine blunted dopamine-induced stellation to 158±18.2% of control values
(Figure 3.5). Application of 2-APB alone had no effect on astrocyte stellation
(119±21.3% of control values) or GFAP area (77±7% of control values). GFAP+
area was also not significantly affected by any of the other treatments (Figure 3.5).
Altogether, these findings indicate that dopamine effects on astrocyte stellation are
attributable to dopamine receptor activation with both D1- and D2-like receptors
playing a role in this process. Additionally, we demonstrate a role for the IP3
receptor activation downstream of dopamine receptor signaling. Finally, while
oxidative processes may play a role in dopamine-induced regulation of GFAP+
area, these effects are likely dissociable from dopamine-receptor mediated
stellation.

3.5

Dopamine treatment elicits broad changes in astrocyte transcriptome
Considering that dopamine treatment can trigger activation of multiple

pathways to induce rapid structural morphogenesis, we profiled genome-wide
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transcriptional changes using RNA seq. We examined astrocyte transcriptomic
changes following brief (20 minutes) and extended (60 minutes) exposure to
exogenous dopamine (75 µM). Brief treatment with dopamine resulted in
enrichment (log2fold values > 2) at 569 (116 down-regulated, 453 up-regulated)
out of 17327 identified genes. Extended treatment with dopamine resulted in
enrichment of 159 (37 down-regulated, 122 up-regulated) out of 17327 genes
relative to control levels. The volcano plot in Figure 3.6 shows RNA-seq results
from all treatment groups (control, 20 min, 60 min). Significantly enriched genes
(log2 fold change >2) are color-coded in red (upregulated genes) and blue
(downregulated genes) with FDR < 0.0001 (horizontal line). A number of genes
with especially large magnitude changes and p-values are labeled. Gene ontology
analysis indicated that biological and developmental process regulation accounted
for 21.1% of differentially enriched transcripts in the 20-minute treatment condition
and for 18.8% of differentially enriched transcripts in the 60-minute treatment
condition. Relevant to our morphological findings, 6.2% of differentially enriched
genes in the 20-minute condition were accounted for by “microtubule-based”, “cell
or subcellular component movement”, and “cell projection organization” categories
(Figure 3.6).

None of these categories were represented in the 60-minute

condition, although 3.5% of all differentially enriched genes were classified as
responsible for “structure morphogenesis”. Relevant to astrocyte function, 40
genes were classified as responsible for ion transport in the 20-minute condition
and 14 as responsible for calcium ion homeostasis in the 60-minute condition.
Prominently represented within the ion transport category were potassium channel
59

genes: 8 out of 40 total. Out of those eight, six genes coded for voltage-gated
potassium channels.

3.6

Functional effects of chronic dopamine
We investigated whether astrocytic voltage-gated potassium channels,

involved in regulation of K+ ion homeostasis (Sontheimer, 1994), are affected by
dopamine treatment. In whole-cell patch-clamp recordings of cells exposed to
control or dopamine-containing media for 60 minutes, we found no main effect of
dopamine treatment on the amplitude of: inwardly rectifying (Kir) currents
[F(1,13)=1.5, p=0.24], delayed rectifier (Kdr) currents [F(1,12)=1.44, p=0.25] or the
A-type (IA) currents [F(1,11)=0.01, p=0.9] (Figure 3.7Ai-ii, Bi-ii, Ci-ii). The only
significant effect was an interaction between dopamine treatment and the injected
voltage step for Kir currents [F(18,234)=1.79, p=0.03] (Figure 3.7Ai-ii). When Kir,
Kdr, and IA data were normalized to the maximal current amplitude in each cell, we
observed no significant main effects of dopamine treatment or treatment by voltage
interactions (Figure 3.7Aiii, Biii, Ciii). The resting membrane potential (RMP) was
not affected by dopamine treatment (control RMP= -67.58 ± 1.72 mV; dopamine
RMP= -66.8 ± 0.93 mV [t(15)=0.3, p=0.75, Student’s t-test]). A decrease in
membrane capacitance after dopamine failed to reach statistical significance
(control=17.1±1.8 pF; dopamine=11.72±1.9 pF [t(16)=1.99, p=0.06]). However,
dopamine treatment significantly increased membrane resistance, although this
was highly variable between cells (control Rm=77.6±36.35 MΩ; dopamine
Rm=312.87±103.77 MΩ ([t(13)=2.43, p=0.03), Student’s t-test]). The increase in
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Rm and the trend toward decreased Cm are consistent with a reduction in GFAP+
cell area seen in immunocytochemical experiments.
Given the contribution of genes that regulate Ca2+ ion homeostasis in the
RNA seq data and functional relevance of intracellular Ca 2+, we also evaluated
astrocytic Ca2+ transients. To do so, we monitored fluorescence of the GFAPdriven Ca2+ sensor, GCamp6f, after exposing the cells to control or dopaminecontaining media for 60-90 minutes. Dopamine exposure had only a mild effect on
the amplitude of spontaneous Ca2+ events reducing them from 4.7±1.1% of
baseline fluorescence in control conditions to 2.9±0.5 % of baseline fluorescence
after incubation with dopamine (p=0.08, Student’s t-test; Figure 3.8A, B).
However, we observed pronounced effects on duration and frequency of astrocytic
Ca2+ transients. In control conditions, spontaneous Ca2+ events were long, lasting
an average of 4.1±0.25 seconds and occurred at a frequency of 0.025±0.001 Hz.
Incubation with dopamine (75 µM) significantly reduced the duration of
spontaneous Ca2+ transients to 2.05±0.11 seconds (p=1*10-16, Student’s t-test),
but increased their occurrence to 0.038±0.002 Hz (p=4.6*10 -7, Student’s t-test;
Figure 3.8A, C, D). A 10-minute pre-incubation with the IP3 receptor blocker, 2aminoethoxydiphenyl borate (2-APB, 50 µM) prior to the 60-minute treatment with
dopamine+2-APB reduced the number of cells displaying spontaneous Ca 2+
transients (from 68% of cells after dopamine alone to 19% of cells after
dopamine+2-APB), had no effect on event amplitude or frequency, and led to a
marked decrease in event duration (Figure 3.8B, C, D). Broad reduction in number
of spontaneously active astrocytes is consistent with the IP 3-mediated Ca2+
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release, although additive effects of dopamine and 2-APB on event duration may
suggest also an IP3 receptor-independent component (Agarwal et al., 2017). In
Ca2+-free media, a very small number of cells (5%, 4 cells) continued to display
spontaneous GCamp6f fluorescence. We observed a total of 11 fluorescence
transients in Ca2+-free media with amplitude, frequency and event duration similar
to those measured in the presence of 2-APB (Figure 3.8B, C, D). Altogether, these
results indicate that a 60-minute exposure to dopamine modulates duration and
frequency of astrocyte Ca2+ signals. However, dopamine treatment has little to no
effect on activity of astrocyte voltage-gated K+ channels.

3.7

Dopamine signaling in astrocytes triggers transcription of CTCF target

genes
Having confirmed gene ontology results that both morphological and ionic
regulatory processes were selectively induced by dopamine, we further analyzed
our RNA-Seq data for mechanistic indicators of potential regulatory processes. To
do this, we first plotted the top differentially enriched transcripts from the control,
dopamine 20 min, and dopamine 60 min conditions in relation to each other (30
genes from each category resulting in 67 distinct genes). This revealed a clear
effect of dopamine treatment and four temporally discrete patterns of
transcriptomic regulation (“off/on/off”, “on/off/off”, “on/off/on”, and “off/off/on”;
Figure 3.9A). To support these results, we used RT-PCR to evaluate levels of
select differentially enriched transcripts in a biological replicate. In line with RNA
seq data, we observed the expected regulation of FosB (off/on/off), Pde10a
(on/off/off), Ap1s3 (on/off/on), and Gpr83 (off/off/on) following treatment with
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dopamine (Figure 3.9Bi-iv). It is notable that in addition to FosB, the “off/on/off”
category prominently featured transient activation of other immediate early gene
family members (e.g. Nr4a3, Atf3, Egr1, Nr4a1, Egr4) among the top differentially
enriched transcripts.
We next examined whether dopamine regulates astrocytic gene expression
ex vivo in hippocampal and striatal brain slices. To do this, we examined genes
present in our in vitro RNA sequencing dataset, but selectively enriched in
astrocytes ex vivo as reported by Zhang et al. (2014). Acute hippocampal and
striatal slices were exposed to dopamine (75 µM + 50 µM SMBS) for 20 minutes
with or without pre-treatment with D1-like dopamine receptor antagonist,
SCH23390 (50 µM), or the D2-like dopamine receptor antagonist, sulpiride (20
µM). The results support our in vitro observations that dopamine induces distinct
patterns of transcriptomic regulation of astrocyte enriched-genes. Exposure to
dopamine lead to a significant increase in expression of Nr4a3 and significantly
downregulated expression of Klf4 in hippocampal slices. However, in striatal slices,
treatment with dopamine did not result in significant differential regulation of any
of the three genes screened (Nr4a3, Klf4, and FosB; Figure 3.10A, B), suggesting
there may be inherent differences among astrocyte from discrete brain regions.
Furthermore, all dopamine-induced alterations in gene expression were absent in
those slices preincubated with either D1-like or D2-like dopamine receptor
antagonists, confirming the role of both D1 and D2-like receptors in mediating
dopamine effects on the astrocyte transcriptome (Fig. 3.10A, B).
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In neurons, such discrete activation patterns have been attributed to
modifications in the chromatin accessibility landscape (Su et al., 2017). One
protein shown to dynamically coordinate chromatin accessibility and genomic
organization in the brain is CTCF, which both regulates the 3D structure of
chromatin as well as defines the boundaries between active and heterochromatic
DNA (Sams et al., 2016; Su et al., 2017; Phillips and Corces, 2009). To evaluate
whether CTCF could mediate dopamine-elicited transcriptomic changes in
astrocytes, we examined promoters of the top differentially expressed genes
(Figure 3.10A) for CTCF motifs. As shown in Figure 3.9C, the results indicated
that 70.15% of the top differentially enriched genes possessed a binding motif for
CTCF, a substantial increase from the expected genome-wide CTCF binding site
prevalence of ~33% (Holwerda and de Laat, 2013). Notably, genes with the CTCF
motif included those validated by qPCR (Figures 3.9 and 3.10). Furthermore, all
of the genes with the “on/off/on” pattern of dopamine-induced transcriptional
regulation possessed the CTCF binding motif whereas genes with the “off/off/on”
pattern had the lowest CTCF motif prevalence.

3.8

CTCF regulation recapitulates morphogenic effects of dopamine
CTCF triggers transcriptional changes by interacting with PARP1 (Yu et al.,

2004; Ong et al., 2013; Han et al., 2017; Zhao et al., 2015), which has been
implicated in behavioral and molecular effects of cocaine (Scobie et al., 2014).
PARP1 both facilitates NAD+-dependent generation of ATP for chromatin
remodeling (Wright et al., 2016) and regulates CTCF binding to target genes via
NAD+-dependent poly-ADP-ribosylation of CTCF (Yu et al., 2004; Ong et al., 2013;
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Han et al., 2017). While there are no direct pharmacological tools for CTCF,
commonly used NAD+-precursors, nicotinamide and nicotinamide riboside, exhibit
opposite effects on PARP1 activity due to their disparate effects on SIRT1, the
negative regulator of PARP1 (Bitterman et al., 2002; Trammel et al., 2016; Sajish
and Schimmel, 2015; Rajamohan et al., 2009). This results in nicotinamide riboside
acting as an ‘antagonist’ of PARP1 and, conversely, nicotinamide acting as an
‘agonist’ of PARP1. We took advantage of this distinction to determine whether
dopamine-induced morphological changes could be linked to PARP1 activation.
To accomplish this, astrocytes were pre-incubated with nicotinamide (5 mM) or
nicotinamide riboside (1 mM) for 15 minutes prior to a 60-minute incubation with
dopamine (75 µM) or control media. Nicotinamide increased astrocyte stellation
and decreased GFAP+ area in the absence of dopamine (Figure 3.11). In the
presence of dopamine, nicotinamide enhanced stellation beyond that seen with
dopamine alone, but maintained reduction in GFAP + area at levels similar to that
seen with dopamine alone. Nicotinamide riboside had no effect on astrocyte
stellation or GFAP+ area when applied on its own, but occluded changes in both
stellation and GFAP+ area when applied in combination with dopamine (Figure
3.11). Similarly, pre-incubation with PARP inhibitor, 3-aminobenzamide (3-AB; 5
mM), completely blocked dopamine-induced stellation. Notably, 3-AB increased
GFAP+ cell area when applied by itself or in combination with dopamine (Figure
3.11B). Another, more potent PARP1 inhibitor, AG-14361 (100 µM), reduced
dopamine-induced stellation (160±21.4% of control values), but had no effect on
GFAP+ cell area (101±9.5% of control values). When applied alone, AG-14361 had
65

similar effects on astrocyte stellation and GFAP+ area as it did in combination with
dopamine (stellation: 142±18.7% of control; GFAP+ area: 127±38.1% of control).
Altogether, these results indicate that dopamine-induced morphological changes
on astrocytes in culture rely on PARP1 activation resulting in recruitment of CTCF
to target genes and remodeling of astrocyte transcriptome.
Western blot analysis revealed that treatment with dopamine or
nicotinamide decreased acetylation of tubulin (Figure 3.12). These findings
suggest PARP1 dependent reduction of microtubule assembly. Increased
stellation, therefore may be indicative of collapse or retraction of existing
membrane and processes rather than generation of new cytoskeleton. In
summary, these findings have implications that dopamine treatment acts similarly
to nicotinamide treatment and that this similarity may stem from regulation of NAD
levels.
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Figure 3.1. Characterization of primary cultures. Widefield images depicting (A) GFAP+
astrocytes, (B) NeuN+ neurons, and (C) Cd11b+ microglia present in primary culture. Imaged
immunopositive fields indicate that cultures consisted of predominately (A) GFAP+ cells, some
(C) Cd11b+ cell contamination, and a negligible contribution of (B) NeuN+ cells. Scale bar, 75
µm.
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Figure 3.2. Elevated extracellular dopamine induces morphological changes in astrocytes.
(A) Widefield images of astrocytes double-stained for GFAP (green) and DAPI (blue) in control
conditions and after exposure to dopamine (75 µM) for 1, 24, or 48 hours (DA 1hr, DA 24hr, DA
48hr). Dopamine induces a prominent increase in the number of primary processes (arrows).
Scale bars, 75 µm. (B) Quantification of the number of primary processes and average GFAP +
cell area. One-way ANOVA for number of processes (F(3,469)=56.64, p<0.0001). One-way
ANOVA for GFAP+ area (F(3,469)=5.52, p=0.001); Bonferroni post-hocs: *, p<0.05, ***, p<0.001
vs. control; #, p<0.05, ##, p<0.01 vs. dopamine 1 hour. Control (n=179 cells), DA 1 hr (n=152
cells), DA 24 hr (n=58 cells), DA 48 hr (n=84 cells).
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Figure 3.3. Dopamine-induced stellation of astrocyte processes is concentration-dependent. (A)
Widefield images of GFAP+ astrocytes following a one-hour exposure to 0.1 µM, 1 µM, 10 µM, and 75
µM dopamine. Scale bars, 75 µm. (B) Quantification of average number of primary processes and
average GFAP+ cell area. One-way ANOVA for number of processes (F(4,325)=11.54, p<0.001); Oneway ANOVA for GFAP cell area (F(4,325)=5.266, p<0.001). Bonferroni post-hocs: *, p<0.05; **, p<0.01;
***, p<0.001 vs. control. Control (n=67 cells), DA 0.1 µM (n=63 cells), DA 1 µM (n=67 cells), DA 10 µM
(n=54 cells), DA 75 µM (n=79 cells).
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Figure 3.4. Oxidation of dopamine does not promote rapid stellation of astrocyte processes.
(A) Representative images of GFAP+ astrocytes in the control conditions and following exposure to
dopamine (75 µM) and N-acetylcysteine (5 mM; DA+NAC). Scale bars, 75 µm. (B) Quantification of
number of primary processes and average GFAP+ cell area following a one-hour exposure to control
media, dopamine, dopamine with NAC, or dopamine with sodium metabisulfite (50 µM; DA+SMBS).
One-way ANOVA for number of processes (F(3,222)=17.56, p<0.001). One-way ANOVA for GFAP+
area (F(3,222)=17.99, p<0.001). Bonferroni post-hocs: ***, p<0.001 vs. control; ###, p<0.001 vs.
dopamine. Control (n=67 cells), DA (n=79 cells), DA+NAC (n=41 cells), DA+SMBS (n=39 cells).
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Figure 3.5. Dopamine-induced morphological changes depend on activation of D1-like and D2like dopamine receptors. (A) Representative images of GFAP+ astrocytes after a one-hour exposure
to dopamine (75 µM) or after exposure to dopamine in the presence of D1-like dopamine receptor
antagonist SCH23390 (50 µM; DA+SCH), D2-like dopamine receptor antagonist, sulpiride (20 µM;
DA+Sulp.), or both SCH23390 and sulpiride (DA+SCH+Sulp.). Scale bars, 75 µm. (B) Quantification of
number of primary processes and average GFAP+ cell area. One-way ANOVA for number of processes
(F(4,453)=17.15, p<0.001). One-way ANOVA for GFAP area (F(4,454)=2.187, p=0.07). Bonferroni
post-hocs: *, p<0.05, ***, p<0.001 vs. control; #, p<0.05, ###, p<0.001 vs. dopamine. Control (n=105
cells), DA (n=116 cells), DA+SCH (n=84 cells), DA+Sulp (n=70 cells), DA+SCH+Sulp (n=84 cells).
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Figure 3.6. Transcriptomic effects of dopamine. (A) Volcano plot of all differentially enriched genes in
control, 20 min, and 1hr dopamine-treatment conditions. Significantly enriched genes (log2 fold change >2)
are color-coded in red (upregulated genes) and blue (downregulated genes) with FDR < 0.0001 (horizontal
line). Notice the abundance of immediate early gene family members among the highly upregulated genes.
(B) A gene ontology analysis of over-represented “biological process” categories in the 20 min condition. The
fraction of the total number of all over-represented (up- and down-regulated) genes is indicated for each
category in the parentheses.

Figure 3.7. Dopamine treatment does not affect astrocytic voltagegated potassium channels. (Ai,Bi,Ci) Representative traces from
astrocytes incubated in control- or dopamine (75 µM)-containing media
showing Kir (inwardly-rectifying), Kdr (delayed-rectifier), and IA (A-type)
K+ currents. (Aii,Bii,Cii) Corresponding I-V plots illustrate mean
amplitude ± SEM of currents for each voltage-gated conductance. (Aiii,
Biii, Ciii) Same as in Aii, Bii,Cii, but with currents normalized to
maximal recorded current in each cell (Kir control (n=9 cells), dopamine
(n=6 cells)); Kdr control (n=8 cells), dopamine (n=6 cells)); IA control
(n=7 cells), dopamine (n=6 cells)). The only significant difference is an
interaction in Aii (see Results). (D) Representative wide-field image of
568-fluorescent dye filled astrocyte with GFAP conjugated to Alexa
Fluor 488, and Dapi. Scale bar, 75 um.
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Figure 3.8. Effects of dopamine treatment on astrocytic Ca2+
signals. (A) Representative “heat map” frames of GCamp6f
fluorescence after a one hour exposure to control (Ai) or dopaminecontaining (Aii) media. Ca2+ fluorescence traces for the three
numbered astrocytes are presented below the image frames.
Vertical dotted lines are drawn at intervals corresponding to the
image frames. (B-C) Cumulative distribution histograms
summarizing the effects of dopamine on amplitude and duration
(half-width) of all recorded spontaneous Ca2+ transients (control
(n=473 evens); dopamine (n=1429 events)). Insets indicate mean
amplitude and duration of Ca2+ events averaged across all identified
astrocytes (control (n=172 cells); dopamine (n=325 cells). ***,
p<0.001, Student’s t-test (t(495)=8.6). (D) Bar histogram, illustrating
dopamine-induced increase in frequency of spontaneous Ca2+
transients. ***, p<0.001, Student’s t-test (t(504)=5.1).
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Figure 3.9. Dopamine regulation of astrocyte transcriptome is
heterogeneous and temporally dynamic. (A) Clustergram
characterizing top DEGs based on expression changes between
treatments. (Bi–Biv), qPCR validation of representative genes from
each class of the DEGs indicated in A. Data are mean ± SEM. Oneway ANOVAs: FosB (F(2,21) = 7.2, p < 0.01); Pde10A (F(2,22) = 14.6,
p < 0.001); Ap1s3 (F(2,19) = 4.4, p < 0.05); Gpr83 (F(2,20) = 19.9, p
< 0.001). Bonferroni post hoc: ***p < 0.001 versus control. **p < 0.01
versus control. *p < 0.05 versus control. ###p < 0.001 versus DA 20
min. #p < 0.05 versus DA 20 min).
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Figure 3.10. DA exposure regulates astrocytically
enriched CTCF response genes in rat hippocampal and
striatal slices. (A) qPCR analysis of astrocyte-enriched
genes from hippocampal slices (n = 9–12 slice experiments
from 7 rats). Data are mean ± SEM. *p < 0.05. (B), qPCR
screening of astrocyte-enriched genes from striatal slice (n
= 9–12 slice experiments from 7 rats). Data are mean ±
SEM. *p < 0.05. (C), CTCF binding motif analysis. Top
Donut chart represents CTCF binding motif analysis of all
top DEGs. Bottom, Four charts represent similar analysis,
but for each of the DEG classes indicated in Figure 3.9A,
with the validated genes in Figure 3.9B, Figure 10A,B
included.
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Figure 3.11. Nicotinamide recapitulates morphological effects of dopamine. (A) Representative
images of GFAP+ astrocytes following exposure to dopamine and nicotinamide (DA+NAM), dopamine
and nicotinamide riboside (DA+NR), nicotinamide alone (NAM), or nicotinamide riboside alone (NR).
Scale bars, 75 µm. (B) Quantification of average number of primary processes and average GFAP+ cell
area. One-way ANOVA for number of processes F(5,239)=18.71, p<0.001; one-way ANOVA for GFAP
area F(5,239)=9.744, p<0.001; Bonferroni post-hocs: ***, p<0.001 vs. control; ##, p<0.01, ###, p<0.001
vs. dopamine.
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Figure 3.12. Dopamine and nicotinamide treatment decrease acetylated tubulin in cultured astrocytes.
(A) Representative blots. (B) Quantification of protein levels in primary cultured astrocytes in response to
Control, Nicotinamide (NAM, 5mM), DA (75µM), or DA & NAM exposure for 1.15hours. * p<0.01 vs. control (2way ANOVA).

CHAPTER 4
THE IMPACT OF ELEVATED EXTRACELLULAR DOPAMINERGIC
SIGNALING ON ASTROCYTES EX VIVO
4.1

Introduction
Emerging evidence is challenging the traditional thought that astrocytes are

morphologically and functionally homogenous throughout the brain; instead,
astrocytes have been found to exhibit both circuit- and region-specific
morphological, functional, and molecular distinctions in both normal and
pathological conditions. Moreover, many studies illustrate how astrocytes are not
only heterogeneous in form and function, but plastic in nature, responding to wide
array of stimuli and conditions both in vitro and in vivo. This morphological and
functional heterogeneity, as well as plasticity, allows astrocytes to serve as active
participants in overall CNS function including modulation of neuronal signaling and
synaptic plasticity. Such roles in overall brain function require close interplay
between astrocytes and their signaling partners, where the structural and
functional relationships are particularly plastic and can change depending on the
individual physiological conditions.
In Chapter 3, I have shown that astrocytes in culture respond to dopamine
with morphological, functional, and molecular alterations. It remains unknown
whether astrocytes are sensitive to dopamine in vivo and whether this may have
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physiological implications. Moreover, despite evidence of structural and functional
plasticity of astrocytes in disease states associated with dysregulated
dopaminergic signaling, it is not clear whether physiological differences in
dopamine exposure impact astrocyte morphology. This chapter highlights a
potential role for physiological increases in dopaminergic signaling over the course
of cocaine self-administration in altering astrocyte morphology and expression
profile of genes implicated in astrocyte-neuron interactions. While several studies
have assessed the role of drug or cocaine exposure and experience on astrocytic
profiles in various brain regions, including the hippocampus and striatum, the role
of elevated extracellular dopamine in physiological conditions of cocaine
experience has not been directly addressed.
Drug addiction develops from a voluntary-like drug-taking behavior to
compulsive-like drug-taking behavior. This shift in the nature of drug-taking
behavior is associated with a transfer of control over drug-taking behavior from the
ventral striatum to the dorsal striatum (Vanderschuren & Everitt, 2004; Everitt &
Robbins, 2013; Wilhuh et al., 2012). The ventral-to-dorsal striatal shift in control
over drug seeking is represented by an increase in phasic dopamine release within
the dorsolateral (DL) striatum, but not within the NAcC, following two and three
weeks of cocaine self-administration (Everitt & Robbins, 2013; Ito et al., 2002;
Wilhuhn et al., 2012). Taken together, these findings reveal that extended cocaine
taking leads to compulsive drug-seeking habits which are associated with a
progressive increase in dorsal striatum dopamine levels.
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4.2

Astrocyte morphometric and molecular properties in ventral and
dorsal striatum following short duration saline experience
We characterized astrocyte density, as well as astrocyte morphometric and

molecular properties in the ventral and dorsal striatum of 7 day (1 h/d) saline
experienced animals. We did not find any significant differences in astrocyte
GFAP+ density or average GFAP+ primary process number, process length,
surface area (um2), or volume (um3) between the two striatal regions following 7 d
experience in operant chambers. While not significant, astrocytes in the ventral
striatum at baseline were depicted as trending towards a more complex structure
(Scofield et al., 2016; Testen et al., 2018). Ventral striatal astrocytes possessed a
slightly larger number of longer primary processes, as well as higher surface area
and volume measures than those in the dorsolateral striatum (Figure 4.3). To
examine baseline molecular changes, the study focused on mRNA expression of
genes in three categories: intrinsic astrocytic genes (Kir4.1 & Kir.7.1), astrocyteastrocyte interaction genes (CX43 & CX30), and astrocyte-neuron interaction
genes (Hevin & Sparc; see Table 4.1 for gene descriptions). There were no
significant sub-regional differences in expression of SPARC, Hevin, Gja1 (CX43),
Kcnj10 (Kir4.1), or Kcnj12 (Kir2.2) mRNA (Figure 4.4). Results show significantly
higher baseline expression of astrocytic Gjb6 (connexin 30) in the dorsolateral
striatum compared to the ventral striatum ([t(10)= 3.333, p= 0.0076, Student’s ttest], Figure 4.4). This finding may align with the observations on trending
morphometric distinctions in astrocytes at baseline, where astrocytes in the
dorsolateral striatum typically present with less complex structural features,
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including fewer and shorter primary processes. Moreover, these morphometric
distinctions among astrocytes could be associated with baseline differences in
astrocyte-astrocyte and astrocyte-neuron physical and functional interactions in
the ventral and dorsal striatum. Certainly, investigation of astrocyte heterogeneity
in morphology, function, and gene expression among striatal subregions and how
it relates to aberrant conditions in disease warrant future study. While our data
show few significant sub-regional differences in the astrocytic properties
addressed, we have only begun to investigate striatal sub-regional astrocyte
heterogeneity, and thus future investigations should include more thorough
investigation of astrocyte morphological, molecular, and functional profiles using
techniques such as electron microscopy, in vivo fast-scan cyclic voltammetry,
patch-clamp recordings of astrocytes’ K+ currents, in vivo calcium imaging, and
whole genome sequencing of astrocytes isolated from dorsal and ventral striatal
brain slices. These represent only a handful of techniques which, together, could
help characterize astrocyte sub-region heterogeneity in the intact striatum.

4.3

Behavioral outcomes: short and extended-access cocaine self-

administration
To characterize the impact of phasic dopamine transmission on NAcC and
dorsal striatal astrocytes, animals were separated into two groups with each
cocaine self-administration animal being paired with a yoked saline control: shortaccess (7 days 1hr/daily sessions) and extended-access (21 days 1hr/daily
sessions). In line with behavioral data published by Wilhuhn et. al (2012), we
observed a significant increase in drug-taking behavior after 1 week (7 d) of
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cocaine self-administration and this increase was largely maintained over the
course of 3 weeks (21 days) cocaine self-administration (Figure 4.1A [n = 5; F(1,
8) = 13.75, P = .006]; Two-way ANOVA). When compared to paired yoked saline
controls, both short-access and extended access groups had achieved significant
increases in drug-taking behavior (active lever presses) by the final day of each
experiment (Figure 4.1B; 7 (SA) or 21 (EA) d ([n = 6,5; F(3, 20) = 14.12, P <
0.0001] One-way ANOVA). Inactive and time-out responding (i.e., non-reinforced
responding) did not change over the course of extended 21 day (1hr/daily
sessions) cocaine self-administration (Figure 4.2A; [n = 5; F(2, 18) = 0.5499, P =
0.5864] One-way ANOVA). However, the number of reinforced responses
significantly increased over the course of the extended 21 day cocaine selfadministration experiment (Figure 4.2B; [n = 5; F( 2, 18) = 23.66; P < 0.0001] Oneway ANOVA). As a result, the ratio of reinforced to total responses (the efficiency
of responding) was significantly elevated in the second and third weeks than in the
first week (Figure 4.2C; [n = 5; F(2, 18) = 28.48, P < 0.0001] One-way ANOVA).

4.4

Duration of cocaine self-administration differentially impacts astrocyte

density and morphology in the ventral and dorsal striatum.
Short-access cocaine SA does not alter astrocyte density in the rat striatum
We investigated whether short access cocaine self-administration
associated with a physiological increase in dopaminergic signaling in the NAcC
(Wilhuhn et al., 2012) would result in changes in astrocyte density, as well as,
morphological alterations to astrocytes when compared to the dorsolateral striatal
astrocytes or yoked saline controls under the same behavioral regime. Our findings
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reveal that short-access cocaine self-administration did not significantly impact
NAcC astrocytic density or morphology (Figures 4.6 and 4.7). Surprisingly, shortaccess cocaine self-administration resulted in a significant increase (3.67±1.2) in
the average number of primary processes per cell in the dorsolateral striatum
(DLS; Figure 4.7; [n = 3; F(3, 8) = 5.526, P = .0237]; One-way ANOVA), yet no
other significant morphometric alterations were found in DLS astrocytes. While not
significant, this same trend was also present in GFAP+ cells within the NAcC of
short duration cocaine experienced animals. Together, these findings suggest that
short duration cocaine self-administration, associated with elevated dopaminergic
signaling in the ventral striatum, leads to an increase in the number of GFAP +
primary processes in the ventral and dorsal striatum. Further, this increase in
process number has been attributed to higher structural complexity of astrocytes
(Scofield et al., 2016; Testen et al., 2018).
Extended-access cocaine SA elicits region-specific alterations in astrocyte density
and morphology in the rat striatum
We next assessed whether extended access, but not short access, cocaine
self-administration would lead to subregion specific alterations in density and
morphology of astrocytes in the DLS when compared with NAcC or saline control
groups. While there was no significant change in density of astrocytes in the DLS,
there was a significant decrease from 13.5±.5 in saline conditions to 9±1 GFAP+
astrocytes per field in the NAcC following extended access cocaine selfadministration (Figure 4.6; NAcC [F(3,4)=8.133, p=0.035]; One-way ANOVA)).
This finding aligns with findings from Scofield et al. (2016) where 10-days
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(2hr/daily) cocaine self-administration results in a decrease in GFAP expression
within the ventral striatum (NAcC). Our results also indicate that extended duration
of cocaine experience leads to significant decreases (NAcC: SA saline = 10.3±1.8,
SA cocaine = 13.7±.33, EA saline = 9±.58, EA cocaine = 8±.58; DLS: SA saline =
7.7±.33, SA cocaine = 11.3±1.2, EA saline = 10.7±.68, EA cocaine = 8.7±.33) in
average number of primary processes per cell in the DLS and NAcC vs yoked
saline control animals and short-access animals (Figure 4.7; DLS [F(3,8 = 5.526,
p = .0237]; NAcC [F(3,8 = 6.276, p = .0170] One-way ANOVAs ). Moreover,
morphological analyses of astrocytes revealed an increase in the length of primary
processes in the DLS following extended duration of cocaine-taking behavior
(Figure 4.8; DLS EA saline = 30.1±2.4, EA cocaine = 41.6±3.2; F(3,38 = 16.82, p
< .0001] One-way ANOVA). No significant changes in GFAP+ cell measures of
surface area (µm2) or volume (µm3) were observed in the ventral striatum (NAcC)
of animals who had undergone short or extended duration of cocaine selfadministration (Figures 4.9 and 4.10). However, astrocytes within the DLS
responded to extended cocaine exposure with both a significant decrease in
GFAP+ surface area (Figure 4.9 and 4.10; DLS EA saline = 10887±1711um2, EA
cocaine = 6010±1130um2; F(3,8 = 9.4, p = .0053] One-way ANOVA) and volume
(DLS EA saline = 2113±277um3, EA cocaine = 941±145um3; F(3,8 = 16.59, p =
.0009] One-way ANOVA)) when compared to saline groups or short-access
cocaine animals. This may indicate a shift to less complex astrocyte-synapse
structural and functional interactions.
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4.5 Effects of cocaine self-administration duration on gene expression in
ventral and dorsal striatal astrocytes
We examined whether short- and extended-access cocaine selfadministration would lead to sub-region specific regulation of astrocytic gene
expression ex vivo in the NAcC when compared to the DLS of cocaine animals or
yoked saline controls under the same regime. Results showed no significant
changes in intrinsic astrocytic gene mRNA expression in the NAcC or DLS
following short- or extended-access cocaine (Figure 4.11). Yet, we did find
significant downregulation of connexin 30 (astrocyte-astrocyte) mRNA expression
following short-access cocaine self-administration in the NAcC (Figure 4.12; [n =
6; (t(9)= 0.992) P < 0.0001]; Student’s unpaired t-test). Downregulation of connexin
30 holds important implications for astrocyte-astrocyte, as well as, astrocyteneuron structural and functional interactions as it is often associated with
regulation of PAPs into the synaptic cleft (Pannasch et al., 2014). In particular, a
decrease in connexin 30 mRNA may translate to an increase in astrocytic process
insertion into the synaptic cleft, and thus an increase in the efficiency of astrocytic
glutamate transporters (i.e., GLT-1 & GLAST; Pannasch et al., 2014; Testen et al.,
2018; Reissner et al., 2015; Scofield et al., 2016; see intro). We also observed
significant downregulation of SPARC in the DLS following extended, but not shortaccess cocaine experience (Figure 4.13; [n= 6; t(9)=4.173) p < .005]; Student’s
unpaired t-test). This decrease in Sparc gene expression may be linked to the
morphometric increase in surface area, volume, and process length. An increase
in process length and volume would suggest increased structural interactions with
86

nearby synapses as Sparc functions to inhibit Hevin’s role in promoting formation
of synaptic specialization. There were no significant alterations in gene expression
in the DLS of short-access animals. While our studies investigate short-term
impact of cocaine self-administration on individual astrocytic morphometric
features, future experiments will address the functional and structural properties of
astrocyte-astrocyte

and

astrocyte-neuron

dopaminergic signaling.
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interactions

following

elevated

Table 4.1

Gene descriptions for RT-qPCR of cocaine and saline-experienced animals
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Figure 4.1. Drug-taking behavior over the course of days or weeks. (A) Active lever presses
during the drug acquisition period over 7 (SA) or 21 d (EA) of self-administration (n = 6, 11). (B)
Active lever presses on the final day of self-administration. Two-way ANOVA for active lever
presses over course of experiments (7 days, F(1,10) = 11.67, p = 0.006; 21 days, F(1,8)=13.75,
p = 0.006). One-way ANOVA for active lever final day summary (F(3,20)= 14.12, p<0.0001).
One-way ANOVA for reinforced lever presses (F(2,18)= 23.66, p<0.0001). One-way ANOVA
for efficiency ratio (F(2,18)=28.48, p<0.0001). Tukey post-hocs: *P < 0.05,**P < .001 ***P <
0.0001; n.s., not significant.
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Figure 4.2. Drug-reinforced responding in cocaine self-administration. (A) The number of
non-reinforced lever presses did not change significantly across the three- week period of drug
self-administration. (B) The number of reinforced lever presses increased significantly across
the three-week experiment. (C) The ratio of reinforced over total number of lever presses
(efficiency) increased in the second and third weeks compared with the first week during the 21
d drug self-administration regime. One-way ANOVA for reinforced lever presses (F(2,18)=
23.66, p<0.0001). One-way ANOVA for efficiency ratio (F(2,18)=28.48, p<0.0001). Tukey posthocs: *P < 0.05,**P < .001 ***P < 0.0001; n.s., not significant.
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Figure 4.3. Astrocytes in dorsal and ventral striatum: 7 days saline density
and morphology. Quantification of GFAP+ (A) Density, (B) Primary process
number, (C) Primary process length (um), (D) Volume (um3), (E) Surface area
(um2). Student’s t-test. Data are mean ± SEM.

92
Figure 4.4. Astrocytes in dorsal and ventral striatum: 7 days saline gene
expression. Quantification of (A) Hevin, (B) SPARC, (C) CX30, (D) CX43, (E)
Kcnj10, & (F) Kcnj12 mRNA expression NAcC and DLS. NAcC and DLS saline 7 d
(n=5, 6). Data are mean ± SEM. **, p<0.01, Student’s t-test (t(10)=3.333).

Figure 4.5. Representative confocal 3D rendered images of depthcoded GFAP+ astrocytes in slice of cocaine-experienced animals.
(A) NAcC SA Cocaine, (B) DLS SA Cocaine, (C) NAcC EA Cocaine, (D)
DLS EA Cocaine. Red = top of stack, blue = bottom of stack. Scale
bar = 20 µm.
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Figure 4.6. Duration of cocaine self-administration differentially affects ventral striatal
astrocyte density. (A,B) Quantification of GFAP positive astrocytes in the (A) NAcC (ventral
striatum) and (B) dorsolateral striatum (dorsal striatum) following 7 or 21 d cocaine or saline
experience (n = 6, 5). Data are mean ± SEM. One-way ANOVA for GFAP+ cells/field in DLS: F3,4
= 1.000, p = 0.4789. One-way ANOVA for GFAP+ cells/field in NAcC: F3,4 = 8.113, *, p = 0.0354.
The number of GFAP+ astrocytes significantly decreased in the NAc Core following extendedaccess cocaine self-administration.
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Figure 4.7. Duration of cocaine self-administration differentially impacts dorsal and
ventral striatal astrocyte primary process number. (A,B) Quantification of average
GFAP+ primary process per cell. (A) One-way ANOVA for process number in NAcC: F3,8
= 6.27, p = 0.0237. Data are mean ± SEM. (B) One-way ANOVA for process number in
DLS: F3,8 = 5.526, p = 0.0170. Data are mean ± SEM. Bonferroni post hocs: #, p< .05 vs.
EA cocaine; *, p<0.05 vs. SA cocaine. n = 3 cells.
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Figure 4.8. Extended-access cocaine self-administration induces alterations in astrocyte
process length in the dorsal striatum. (A,B) Quantification of average primary process length
(um) in (A) NAcC and (B) DLS following 21 d cocaine self-administration. Data are mean ± SEM.
One-way ANOVA for process number: F3,38 = 16.82, p < 0.0001; Bonferroni post hocs: ****, p<
0.0001 vs. SA cocaine or saline; **, p< 0.001 vs. EA saline; *, p<0.05 vs. EA cocaine. SA saline,
SA cocaine, EA saline, & EA cocaine (n=3 cells).

97
Figure 4.9. Extended-access cocaine self-administration induces alterations in astrocyte
surface area in the dorsal striatum. (A,B) Quantification of GFAP+ surface area (um2) in (A)
NAcC and (B) DLS following 7 or 21 d cocaine self-administration. Data are mean ± SEM. Oneway ANOVA for GFAP+ surface area (um2), (DLS): F3, 8 = 9.400, p = 0.0053; Bonferroni post hocs:
**, p< 0.01 vs. EA saline; *, p< 0.05 vs. EA saline.

98
Figure 4.10. Extended-access cocaine self-administration induces alterations in
astrocyte volume in the dorsal striatum. Quantification of GFAP+ volume (um3) in
(A) NAcC and (B) DLS following 7 or 21 d cocaine self-administration. Data are mean
± SEM. One-way ANOVA for GFAP+ volume (DLS): F3, 8 = 16.65, p = 0.0008; Bonferroni
post hocs: ##, p< 0.01 vs. EA saline; **, p< 0.01 vs. EA cocaine. NAcC saline & cocaine
(n=3 cells), DLS saline & cocaine (n=3 cells).

Figure 4.11. Dopamine regulation of intrinsic
astrocyte gene expression. Quantification of (A, C)
Kcnj10 (Kir4.1) or (B, D) Kcnj12 (Kir2.2) mRNA
expression in NAcC and DLS following 7 or 21 d
cocaine self-administration. Data are mean ± SEM.
NAcC saline & cocaine (n=5, 6), DLS saline &
cocaine (n=5, 6).
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Figure 4.12. Dopamine regulation of astrocyteastrocyte interaction-type gene expression.
Quantification of (A, C) CX43 (Gja1) or (B,D) CX30
(Gjb6) mRNA expression in NAcC and DLS following
7 or 21 d cocaine self-administration. Data are mean
± SEM. ***, p<0.0001, Student’s t-test (t(9)=9.992);
(n=5, 6), DLS saline & cocaine (n=5, 6).
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Figure 4.13. Dopamine regulation of astrocyteneuron
interaction-type
gene
expression.
Quantification of SPARC (A, C) and Hevin (B, D) mRNA
expression in NAcC and DLS following 7 or 21 d cocaine
self-administration. Data are mean ± SEM. **, p<0.005,
Student’s t-test (t(9)=4.173); (n=5, 6), DLS saline &
cocaine (n=5, 6).
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CHAPTER 5
DISCUSSION
5.1

Summary of findings

The studies presented in this document provide novel implications for the effects
of extracellular dopamine on astrocyte morphogenic, molecular, and functional
profiles in vitro and in vivo. In illustrating the impact of dopamine exposure on
cultured astrocytes, we found that elevated extracellular dopamine induced
pronounced stellation of astrocytic processes and a reduction in astrocyte area
positive for the intermediate filament marker, GFAP. This dopamine mediated
effect was blunted by exposure to dopamine receptor antagonists or by inhibition
of PARP1, suggesting a dopamine receptor-mediated, PARP1-dependent
signaling as the source of morphological changes. Furthermore, we showed that
extended exposure of astrocytes to dopamine drives a set of functional adaptations
distinct from those previously reported following acute dopamine treatment in vitro.
Critically, we demonstrated for the first time that at the genome-wide level CTCF
target genes are a prominent marker of astrocyte transcriptional response to
dopamine. In the second part of this thesis, we evaluated sensitivity of astrocytes
Galloway, A. G.*, Adeluyi, A. A.*, O’Donovan, B., Fisher, M. L., Rao, C. N…. & Ortinski,
P. I. (2018). Dopamine triggers CTCF-dependent morphological and genomic
remodeling of astrocytes. Journal of Neuroscience. Reprinted here with permission from
publisher. * indicates equal contributions
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to region-specific physiological increases in dopamine using a behavioral model of
short- and extended-access cocaine self-administration. This regime was modeled
after experiments published by Wilhuhn et al., in 2012 illustrating experiencedependent and region-specific physiological increases in dopamine using a
behavioral model of short- and extended-access cocaine self-administration.
Using this model, results show extended cocaine experience led to a significant
decrease in expression of GFAP+ astrocytes in the NAcC. Along with this
observation, extended duration cocaine elicited increases in stellation of
astrocytes in the NAcC. While drug experience had no effect on any other
morphogenic properties of ventral striatal astrocytes, significant increases in
GFAP+ process length, surface area, and volume were observed in the DLS
following extended-access saline or cocaine self-administration. These findings
are consistent with a significant downregulation of Gjb6 (CX30) as this would allow
for extension of processes and may contribute to closer structural and functional
relationships with nearby synapses. Interestingly, extended experience alone
significantly affects astrocyte morphometric properties with an observed increase
in GFAP+ primary process length, surface area (um2), and volume (um3).
Furthermore, extended drug experience was found to significantly reduce GFAP +
volume and increase the average length of primary processes in the DLS when
compared to yoked saline controls. While not significant, extended exposure to
cocaine also led to a downward trend in GFAP+ surface area and process number
when compared to paired saline control animals. Taken together, duration of
cocaine self-administration exerts significant, yet subregion-specific and
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temporally distinct alterations in striatal astrocyte morphogenic and molecular
properties in vivo. These experiments relied on prior findings of regional
differences in dopamine levels after cocaine exposure, but did not specifically
measure dopamine levels in the study’s experimental groups. Results provide
evidence that duration of cocaine experience differentially impacts morphometric
and molecular plasticity of astrocytes in ventral (NAcC) and dorsal (dorsolateral)
striatum of rat. Future experiments will directly test the extent to which this plasticity
depends on dopamine signaling in astrocytes in vivo.

5.2

Astrocyte sensitivity to duration of dopamine exposure in vitro and

cocaine experience in vivo
Astrocyte sensitivity to duration of dopamine exposure in vitro
One line of evidence that supports duration of exposure as a factor relevant
to dopamine-mediated response comes from our functional analysis of astrocyte
Ca2+ signaling. Substantial evidence indicates that dopamine plays a role in
modulation of Ca2+ signaling in astrocytes. Specifically, acute application of
dopamine or dopamine receptor agonists, such as SKF83959, to astrocytes in
culture has generally been found to induce elevations in cytosolic Ca2+ via an IP3mediated release from intracellular stores (Vaarmann et al., 2010; Parpura &
Haydon, 2000; Lee at al., 2004; Liu, 2009; Jennings & Rusakov, 2016; Jennings
et al., 2017). Further, astrocytes from cortical and hippocampal cultures express a
distinct phosphatidylinositol (PI)-linked D1-like receptor coupled to PLC by Gαq,
which upon activation leads to an increase in intracellular calcium levels (Liu et al.,
2009, Ming et al., 2006). Our results indicate that extended treatment with
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dopamine decreased the duration and amplitude of Ca2+ transients, the majority of
which were dependent on IP3 receptor activation (Figure 3.8). However, a onehour dopamine treatment increased Ca2+ event frequency (Figure 3.8). The
distinction between acute and chronic effects of dopamine receptor stimulation has
been reported in studies of NMDA-receptor mediated neuronal signaling
(Schilström et al., 2006; Ortinski et al., 2013, Ortinski, 2014). For example,
Schilström et al. (2006) indicated that a brief exposure to a D1 agonist, SKF81297
produces a delayed increase in NMDA receptor-mediated currents with an even
longer delay observed after blockade of dopamine transport. Given the welldocumented behavioral and molecular differences driven by temporal pattern of
exposure to elevated dopamine (Ortinski et al., 2012; Knackstedt et al., 2010),
understanding the extent of astrocytic contribution to these differences is an
important future direction. Our morphological data from astrocytes in culture reveal
a dramatic dopamine-induced shift in morphology from a fibroblast-like form to and
stellated form, with over a 2-fold increase in the number of GFAP+ primary
processes per cell. (Figure 3.2) These morphological changes persisted for 24and 48-hour dopamine exposure; however, astrocytes were largely able to revert
to their original polygonal form after being kept for 24-hours in dopamine-free
media. Further, our sequencing data indicate that even at relatively short
timescales (20 vs. 60 minutes) several distinct patterns of gene regulation can be
distinguished at the genomic level (Figure 3.9). This is characterized most
prominently by a sustained upregulation of genes involved in structure
morphogenesis, kinase signaling, and signal transduction following a long
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exposure to dopamine and a transient up-regulation of immediate early genes after
a brief exposure to dopamine.
Astrocyte sensitivity to duration of dopamine exposure in vivo
A number of studies revealed alterations in astrocyte morphometric
properties and astrocyte-synapse relationships following 10 days cocaine selfadministration (Scofield et al., 2016; Testen et al., 2018; Moussawi et al., 2009).
In two studies published in 2016 by Scofield et al., and 2018 by Testen et al.,
astrocytes within the nucleus accumbens core (NAcC) of the ventral striatum
responded with decreased volume, surface area, and synaptic colocalization
following cocaine self-administration and extinction, compared to NAc astrocytes
from saline-administering animals. In a subsequent study, investigators assessed
the effects of cocaine-self administration following the last drug self-administration
session (day 10) and found no significant changes in NAc astrocytes morphometric
properties after self-administration alone (Testen et al., 2018). To our knowledge,
no studies exist which have examined dopamine’s effects on morphology of dorsal
striatal astrocytes in a cocaine-self administration model. In line with data from
Testen et al., (2018), we see no significant alterations in astrocytes morphometric
properties (surface area, volume, primary process count, process length) in the
NAcC following short (7 days) of cocaine self-administration experience with
samples being taken 24 hrs after the final session. As it has been found that
astrocytes respond to various experiences, including drug exposure, with dynamic
alterations in cell morphology. Importantly, these changes depend on the
conditions of drug exposure (i.e., investigator administered or self-administered),
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duration, drug type, and timepoint at which samples are harvested following the
last period of drug exposure. However, we did find a significant decrease in density
of GFAP+ cells in the NAcC following 21 days cocaine-self administration and a
significant decrease in primary process number, suggesting that long term cocaine
self-administration may lead to alterations in ventral striatal astrocytes.
Furthermore, our studies reveal a temporally and regionally distinct influence of
cocaine self-administration on astrocytes in the dorsolateral striatum. For example,
short-access (7 d) cocaine self-administration lead to a significant increase in
primary process number when compared to saline controls; however, no significant
alterations in number of primary processes were seen following extended-access
cocaine self-administration. Furthermore, while there was no observed change in
the number of primary processes following extended drug experience, there was
an observed increase in primary process length in the dorsolateral striatum not
seen following 7-day drug experience. Interestingly, there was an observed
increase in morphometric properties following extended operant chamber
experience (yoked saline controls), including an increase in process length,
surface area, and volume. Since astrocytes have been found to respond to simple
learning tasks and motor activity with changes in morphology, extended “training”
experience in the operant chamber may explain alterations in astrocytes following
extended-, but not short-access saline self-administration. These results provide
insights into the influence of cocaine use on astrocytes within striatum and inform
both regional heterogeneity as well as temporal dynamics of astrocyte
responsiveness to cocaine self-administration.
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5.3

Possible mechanisms for dopaminergic regulation of astrocyte

morphological, molecular, and functional profiles in vitro: implications for role
of dopamine in altering astrocytes in addictive phenotype.
Dopamine-mediated morphological changes
This study focused on two morphological features of cultured astrocytes,
primary process stellation and GFAP+ area, as notable responses to dopamine
treatment (Figure 3.2). Subsequent experimentation revealed these two
morphological measures to be dissociable. For example, process stellation was
strongest after treatment with high dopamine concentrations whereas increase in
GFAP+ area was strongest after treatment with low dopamine concentrations
(Figure 3.3). Similarly, profound suppression of GFAP+ cell area following
combined treatment with dopamine and antioxidants contrasted with the lack of
changes in process number following a similar treatment (Figure 3.4).
Treatments with cAMP analogues have been observed to trigger
morphological changes in cultured astrocytes (Won and Oh, 2000; Moonen, 1975;
Paco et al., 2016). However, sensitivity of astrocyte morphology to elevated
dopamine has, to our knowledge, only been reported in one other study (Koppel
et al., 2018). In that report, dopamine-induced stellation of cortical astrocytes was
blocked by propranolol, a  adrenoreceptor antagonist. Our in vitro results support
a direct role of dopamine receptors in regulation of astrocyte morphology. Thus,
we found that both D1-like receptor antagonist, SCH23390, or D2-like receptor
antagonist, sulpiride, were effective at blunting dopamine-induced stellation of
astrocyte processes in culture (Figure 3.5). Interestingly, when applied together,
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both D1- and D2-like receptor antagonists were less effective in blunting dopamine
induced stellation than either antagonist by itself. It is possible that these
dopamine-mediated receptor effects on astrocyte morphology are due to
competitive binding of antagonists to D1/D2 heterooligomers (Beaulieu and
Gainetdinov, 2011; Rashid et al., 2007; Hasbi et al., 2010; Lee et al., 2004;
Jennings and Rusakov, 2016). The effects on GFAP+ morphology when both D1like and D2-like receptor antagonists were applied together prior to dopamine
application were surprising given the classical notion that D2-like receptor
activation decreases cytoplasmic cAMP levels. A possible explanation could
involve a novel phosphatidylinositol (PI)-linked D1-like receptor found in both
astrocytes and neurons, which couples to PLC by Gαq and increases intracellular
Ca2+ levels (Liu et al., 2009, Ming et al., 2006). Another explanation could involve
an interaction of the antagonists with Gq-PLC pathway-coupled D1/D2 receptor
heterooligomers (Beaulieu and Gainetdinov, 2011; Rashid et al., 2007; Hasbi et
al., 2010; Lee et al., 2004; Jennings and Rusakov, 2016). Indeed, we show that
blockade of IP3 receptors activated downstream of PIP2 hydrolysis by PLC
reduced dopamine-induced astrocyte stellation. Therefore, our results suggest that
cAMP increase may not be necessary for dopamine-induced stellation.
Dopamine and NAD+/PARP1-dependent regulation of CTCF target genes
We find that the dramatic alterations in astrocyte morphology triggered by
dopamine treatment may be due to significant modifications in chromatin
accessibility.

Across the genome, the expected genome-wide binding site

prevalence of CTCF is ~33% (Holwerda and deLaat, 2013). However, prevalence
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of CTCF binding motifs in the top genes significantly altered by dopamine
treatment was found to be between 70–100%. Complementing the evidence
showing that CTCF orchestrates genomic re-organization underlying learning and
memory (Sams et al., 2016), we highlight a possible NAD+/PARP1-role linking
dopamine signaling in astrocytes to epigenetic regulation of the chromatin
landscape.
Our data suggest that dopamine activates PARP1, a NAD+-dependent polyADP-ribose polymerase that promotes CTCF binding to transcription initiation sites
(Yu et al., 2004; Ong et al, 2013; Han et al., 2017; Zhao et al., 2015), leading to
changes in astrocyte morphology through alterations in 3D chromatin architecture.
We speculate that protein kinase C (PKC) is a likely mediator of coupling between
dopamine receptors and PARP1/CTCF activation. Both D1- and D2-like dopamine
receptors can stimulate PKC (Neve et al., 2004; Ortinski et al., 2015) and PKC is,
in turn, known to promote PARP1 production and formation of PARP1/CTCF
complexes (Henderson et al., 2017). We find that PARP1 agonist, nicotinamide,
recapitulates, while PARP1 antagonists, nicotinamide riboside, 3-AB, or AG14361, occlude dopamine-induced stellation and dopamine-induced decrease in
GFAP+ area (Figure 3.11). Our observation that co-administration of dopamine
and nicotinamide results in more pronounced effects than treatment with either
dopamine or nicotinamide alone, suggests that dopamine may not recruit all of the
available PARP1 pool. Furthermore, the nicotinamide/dopamine synergism
supports PARP1-dependent generation of nicotinamide (Sajish and Schimmel,
2015) rather than regulation of PARP1 protein levels. This is indirectly supported
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by the sequencing data indicating a lack of PARP1 transcript enrichment following
either 20 or 60 minutes of dopamine treatment (log2fold values of –0.130 and –
0.134, respectively). Our observation that nicotinamide riboside or AG-14361 did
not evoke any morphological changes by themselves and only partially suppressed
morphological effects of dopamine treatment suggests that dopamine effects on
astrocyte morphology involve both PARP1/NAD+-dependent as well as
PARP1/NAD+-independent processes. Indeed, a recent finding demonstrated that
a 3-hour dopamine treatment of cortical astrocytes induced expression of BDNF
(Koppel et al., 2017), a SIRT1-dependent process (Zocchi and Sassone-Corsi,
2012). SIRT1 and PARP1 are mutually inhibitory (Sajish and Schimmel, 2015), but
both SIRT1 and PARP1 rely on NAD+ as a substrate, potentially leading to a
cyclical pattern of SIRT1/PARP1 activation which could serve as the basis of
astrocyte sensitivity to duration of dopamine exposure. Dopamine-induced
inhibition of specific sets of genes that lack CTCF binding sites in their promoter
regions, highlighted by our sequencing data, may be an indicator of such a
relationship.
Dopamine regulation of astrocyte transcriptome
Dopamine had distinct effects on the transcriptome of cultured astrocytes
at 20 and 60 min post treatment. Additionally, we observed that dopamine
regulates expression of astrocyte-enriched transcripts in acutely isolated brain
slices and that these effects may be attenuated by antagonists at D1- and D2dopamine receptors. The differences in dopamine effects on RNA levels between
striatal and hippocampal slices reported here, extend previous work from Chai et
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al. (2017), which detailed differentially expressed gene profiles in these two
structures. Approximately ¾ of the top 40 genes enriched in both hippocampus
and striatum in Chai et al. experiments are represented in our RNA-Seq dataset,
indicating substantial overlap between ex vivo and in vitro observations at the
transcriptome level. Furthermore, the genes that we validated by qPCR (FosB,
Klf4, Nr4a3, PDE10a, Gpr83, Ap1s3) all possess a CTCF binding motif. Indeed,
our RNA-Seq data analysis reported over-representation of CTCF binding motifs,
indicating a coordinated gene network response to dopamine signaling.
Implications for dopamine role in altering astrocytes in addictive phenotype.
Astrocytes form extensive networks of coupled cells via gap-junctions, and
changes in gap-junction gene expression or protein level often reflect a change in
astrocytic network architecture and function (Chai et al., 2017; Meunier et al., 2017;
Clasadonte & Haydon, 2014). For example, double knock-out of Connexin 43 and
Connexin 30 has been found to completely ablate gap-junction coupling in
astrocytes, and thus blunts astrocyte-astrocyte and astrocyte-neuron signaling
mechanisms (Theis et al., 2003). In fact, connexin 30 (Gjb6) is distinctly found to
be expressed in astrocytes and has been shown to regulate the structural plasticity
(extension) of astrocytic processes into the synaptic cleft (Clasadonte & Haydon,
2014). Interestingly, our data reveal that exposure of cultured astrocytes to DA for
20 and 60 minutes leads to significant changes in gap-junction associated
connexin mRNA expression, including significant upregulation of connexin 30 – a
protein which may stabilize astrocytic processes during the morphological shift
from a polygonal to a stellated astrocyte following DA exposure in vitro. We also
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found significant upregulation of connexin 30 (astrocyte-astrocyte) mRNA
expression following extended-access cocaine self-administration in the NAcC
(compared to SA cocaine). Regulation of connexin 30 holds important implications
for astrocyte-astrocyte, as well as, astrocyte-neuron structural and functional
interactions. As the second most predominant astrocytic gap-junction connexin in
the brain, connexin 30 has been shown to regulate the dynamic interactions among
astrocytes and neurons and play an important role in governing CNS physiology
and behavior, including synaptic plasticity and learning-associated processes
(Pannasch et al., 2014; Clasadonte and Haydon, 2014). For example, investigators
observed an associated increase in fine process or PAP extension into the
synaptic cleft in the hippocampus of connexin 30 knockout mice (Pannasch et al.,
2014). This morphological change in astrocytes was associated with an increase
in astrocytic GLT-1 activity leading to an overall decrease in overall excitatory
transmission, as well as impairments in contextual memory processes (Pannasch
et al., 2014). Studies of effects of drug self-administration on astrocyte structural
components reveal that 10 days of cocaine self-administration and/or withdrawal
leads to decreases in astrocyte morphometric features, including a decrease
astrocyte-neuron structural interaction (Scofield et al, 2016; Testen et al., 2018).
Moreover, this decrease in morphometric properties was associated with a
decrease

in

astrocyte-mediated

control

over

synaptic

excitability

via

downregulated expression and activity of astrocytic glutamate transporter, GLT-1.
Thus, the observation short-access (7 d) cocaine self-administration leads to
downregulated expression of connexin 30 mRNA in ventral striatal astrocytes may
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be associated with the subsequent increase in primary process number in
astrocytes seen in extended-access (21 d) conditions. This finding would, in
theory, be associated with higher structural and functional interplay among
astrocytes and neurons, and thus an increase in astrocyte-mediated glutamate
uptake efficiency would be expected (Scofield et al., 2016; Pannasch et al., 2014;
Clasadonte and Haydon, 2014). However, aside from an upward trend in average
GFAP+ primary process number, there were no other observable alterations in
morphology of astrocytes in ventral striatum of cocaine-experienced rats. Yet,
GFAP represents a relatively minor fraction of overall astrocyte cell architecture
and is not localized in peripheral processes where neuronal and synaptic contact
is made (Scofield et al., 2016; Pannasch et al., 2014; see intro). The current
imaging methods used pose limitations, as imaging of PAPs-synapse relationships
and structural plasticity of PAPs requires advanced microscopic methods, such as
high-resolution electron microscopy. In the future, techniques offering detailed
analysis of astrocyte structural components will be adopted.
Dopamine may trigger cAMP production via activation of D1-like dopamine
receptors, expressed by astrocytes along with other dopamine receptor subtypes
(Miyazaki et al., 2004; Shao et al., 2013; Mladinov et al., 2010; Khan et al., 2001;
Nagatomo et al. 2017). D1-induced production of cAMP has been linked to release
of astrocytic Ca2+ from internal stores, an important hallmark of astrocyte-toastrocyte, astrocyte-to-neuron, and astrocyte-to-vasculature signaling (Jennings et
al., 2017; Chai et al., 2017). Indeed, both structural and functional astrocyte
adaptations have been reported in models of neurologic disease linked to
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dysregulated dopamine signaling. For example, Parkinson’s disease is associated
with hypertrophy of astrocytic processes, a feature of reactive astrocytosis (Booth
et al., 2017), while cocaine use has been linked to a reduction of astrocyte surface
area and reduced interaction with synapses (Scofield et al., 2016). In contrast to
these results, our in vivo experiments reveal no significant differences in GFAP+
surface volume in the NAcC following short or extended-access drug selfadministration, but a dramatic increase in average GFAP+ surface volume in the
dorsolateral striatum following extended-access cocaine exposure.
Furthermore, a number of studies have demonstrated that dopamineinduced increase in astrocytic Ca2+ impacts cellular respiration mechanisms
coupled to PARP1 and sirtuin activation (Requardt et al., 2010; Requardt et al.,
2012; Gupte et al., 2017; Verdin, 2015). CTCF triggers transcriptional changes by
interacting with PARP1 (Yu et al., 2004; Ong et al., 2013; Han et al., 2017; Zhao
et al., 2015), which has been implicated in behavioral and molecular effects of
cocaine (Scobie et al., 2014). PARP1 both facilitates NAD+-dependent generation
of ATP for chromatin remodeling (Wright et al., 2016) and regulates CTCF binding
to target genes via NAD+-dependent poly-ADP-ribosylation of CTCF (Yu et al.,
2004; Ong et al., 2013; Han et al., 2017). Recent studies have shown that CTCF
regulates both chromatin remodeling (Wright et al., 2016) and chromatin insulation
(Yu et al., 2004, Ong et al., 2013), thereby organizing transcriptional regulation of
distinct gene suites in response to cellular signaling. However, it is unknown
whether dopamine- or dopamine receptor-induced structural or genomic changes
are linked to PARP1/CTCF interaction.
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We also assessed dopamine- or dopamine receptor-induced structural or
genomic changes potentially linked to PARP1/CTCF interaction. We demonstrate
that dopamine receptor signaling generates pronounced morphological changes
in cultured astrocytes which rely on PARP1 activation and are accompanied by a
dynamic regulation of the astrocyte transcriptome including, most prominently,
specific enrichment of genes containing CTCF motifs in promoter regions. Our
results highlight a novel PARP1/CTCF-dependent mechanism that drives
dopamine-induced morphological changes and associated transcriptional profile in
astrocytes.

5.4

Caveats of investigating dopaminergic reactions in vitro
Dopamine can oxidize in culture media (Clement et al., 2002) and reactive

oxygen species can trigger morphological changes in astrocytes including cell
hypertrophy, swelling/thickening of processes, and increased GFAP expression,
collectively referred to as reactive astrocytosis (Vaarmann et al., 2010). Of note,
individual processes were found to be thicker following dopamine treatment,
however, morphological changes associated with dopamine exposure persisted in
the presence of antioxidants, NAC or SMBS, arguing against oxidative processmediated reactivity. Moreover, the study observed variable, but consistent
downregulation of GFAP+ area (Figures 3.2 - 3.4, Figure 3.11), arguing against
swelling of existing processes as mediators of dopamine-induced morphological
changes. Furthermore, RNA seq indicated only small changes in GFAP transcript
(log2fold value of 1.2 at 60 minutes of treatment with dopamine), a result that was
confirmed with RT-qPCR (not shown). Finally, cross-referencing with published
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reactive astrocyte transcriptome revealed little to no overlap with RNA seq data.
Out of the top 100 reactive astrocyte genes in Zamanian et al. (2012), three were
enriched at above log2fold level in our data set (Gdf15, Srxn1, and Asns). Lcn2
and Serpina3n identified as the prominent novel markers of astrocytic reactivity
(Zamanian et al. 2012) displayed minimal changes in our dataset after one hour of
treatment with dopamine (log2fold values of 0.1 and –0.9, for Lcn2 and Serpina3n,
respectively). Therefore, in conjunction with prior studies that support antiinflammatory effects of dopamine (Yan et al., 2015; Beck et al., 2004; Shao et al.,
2013), results illustrated that dopamine treatment did not promote a reactive state
that could account for the observed morphological or transcriptome changes in our
cultured astrocytes. This, however, could be different for astrocytes that
experience withdrawal from elevated dopamine as reported in animals withdrawn
from experimenter or self-administered cocaine (Fattore et al., 2002; Bowers and
Kalivas, 2003).

5.5

Astrocytes and dopamine in vivo and ex vivo: current limitations and

future directions
In this thesis, results reveal regional and exposure-dependent cocaineinduced regulation of astrocytes morphological and molecular profiles in the ventral
and dorsal striatum. In trying to evoke physiological increases in dopaminergic
efflux in the ventral and dorsal striatum, this study modeled methods and results
published by Wilhuhn et al., 2012. Animals were trained to self-administer cocaine
for 1h/d for 21 days. Using in vivo fast scan cyclic voltammetry, Wilhuhn et al.,
revealed that during the first week of cocaine experience dopamine levels
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increased in the NAcC experience, but during the second and third weeks of
cocaine self-administration dopamine levels increased in the dorsolateral striatum
(2012). Behavioral results from this study recapitulate those findings from Wilhuhn
et al., showing increased drug-seeking behavior with increasing duration of
cocaine experience that is associated with a shift in elevated dopaminergic
signaling from the ventral to the dorsal striatum (2012). Hence, observations of
elevated extracellular dopamine-mediated dynamic alterations in morphological,
molecular, and functional profiles of astrocytes in culture may be relevant to
dopamine effects in ex vivo experiments where an impact on astrocyte morphology
and gene expression is observed. Specifically, in addressing effects of elevated
extracellular dopamine on cultured astrocytes results suggest that these dramatic
shifts in morphological, proteomic, and genomic profile rely on PARP1/CTCF. This
novel dopamine mediated PARP1/CTCF-dependent mechanism of microtubule
and cytoskeletal remodeling of astrocytes was accompanied by alterations in
astrocytes function. Thus, investigation of the impact of elevated dopaminergic
signaling on astrocytes relating how findings of DA-induced PARP1/CTCF
mediated adaptations in astrocytes in vitro relate to morphological alterations ex
vivo and in vivo is needed.
In last 5 to 10 years, emerging evidence reveals that astrocytes are
heterogeneous and plastic in nature, presenting discrete region-dependent
functional roles in regulating synaptic transmission. Moreover, models of
dysregulated dopamine signaling in neurobiological diseases reveal regionspecific aberrations in astrocyte form and function which contribute to progression
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of disease. Together, these findings hold important implications for dopamine’s
effects on astrocytic profiles in disorders associated with alterations in
physiological dopaminergic signaling. Various studies have investigated the role
of drug or cocaine exposure and experience on astrocytic profiles in various brain
regions, including the hippocampus and striatum; however, the role of elevated
extracellular dopamine in physiological conditions of cocaine experience has not
been directly addressed. Here, results show astrocytes may be differentially
sensitive to duration of elevated extracellular dopamine ex vivo using a behavioral
model of short- vs. extended-access cocaine self-administration associated with
temporally dynamic elevations in dopaminergic activity in striatum. Future
investigations would need to address the direct and indirect impact of dopamine in
exerting morphological, functional, genomic, and proteomic changes in astrocytes
in models of substance abuse. Moreover, there is a crucial need of investigation
of dynamic astrocyte responses in form and function, their resulting interactions
with synapses, and their role in promoting disordered behaviors in the face of
dysregulated dopaminergic signaling.

5.6

Conclusion
Substance use disorder(s) represent a major public health issue, as

individuals diagnosed with this disease often experience severe psychological and
often physical distress with serious consequences in their ability to navigate and
function normally in day-to-day life. The transition from voluntary drug-seeking to
compulsive drug‐seeking habits in substance use disorders depends on transfer
of controls over behavior from the ventral to the dorsal striatum (Yager et al., 2015;
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Everitt & Robbins, 2005; Everitt & Robbins, 2013; Everitt et al., 2008). Moreover,
this transition of control relies on the aberrant recruitment of dopamine‐dependent
plasticity processes within spiraling neuronal circuits (Haber et al., 2000). Studies
now reveal how exposure to drugs of abuse, including cocaine, also trigger
morphological, molecular, and functional adaptations in astrocytes within the
striatum which contribute to the intrastriatal transitions observed during the
development of substance use disorders. In the past decade, emerging
pharmacological interventions aiming to restore the astrocytic mechanisms
responsible for maintaining neuronal homeostasis have focused on the role of
drug-induced alterations in glutamatergic signaling in the NAc. Importantly, novel
therapeutic approaches in regulating astrocytic glutamate activity, altered by
chronic exposure to substances of abuse, have been found to prevent
reinstatement and relapse in both preclinical and clinical investigations. While
several studies show evidence of astrocyte roles in regulating extracellular
glutamate concentrations in the NAc, there is a critical need for investigation of
adaptations of astrocytes in the dorsal striatum, where associative dopaminergic
mechanisms govern compulsive drug‐seeking behavior and reinstatement of drug
use.

Importantly,

drug‐induced

alterations

in

glutamatergic

homeostasis

maintained by astrocytes in the striatum may interact with dopaminergic
mechanisms associated with astrocytes and neurons to promote aberrant plasticity
which may contribute to the maintenance and progression of addictive-like
behaviors. Thus, the lack of research on astrocytes and their interactions with
dopamine represents an essential future direction in research of substance use
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disorders. Taking advantage of the growing evidence that astrocytes play a critical
regulatory role in glutamate and dopamine transmission in the striatum, this study
explored how dopamine signaling drives pronounced structural and functional
adaptations in cultured astrocytes. These adaptations are associated with distinct
short- and long-term changes in the astrocyte genome that are consistent with
transcriptional effects of the PARP1/CTCF complex and PARP1-mediated NAD+
signaling. Importantly, results highlight a novel dopamine-induced PARP1/CTCFdependent process that drives morphological changes associated with changes in
transcriptional profile in astrocytes exposed to elevated concentration of
dopamine. This work also reveals astrocytes may be differentially sensitive to
duration of elevated extracellular dopamine using a behavioral model of short- vs.
extended-access cocaine self-administration associated with temporally dynamic
elevations in dopaminergic activity in striatum.
Overall, the findings from this study illustrate temporally dynamic morphological
and molecular alterations in astrocytes in the presence of elevated physiological
dopamine; however, the direct impact of dynamic astrocyte response to dopamine
on neuronal energy homeostasis, neuronal signaling, and behavioral output in the
context of dopamine-related disorders remains to be examined. Thus, future
experiments will aim to elucidate the direct impact of physiological elevated
dopaminergic signaling on astrocytes ex vivo and in vivo, as well as assess how
these dopamine-mediated adaptations relate to findings of PARP1/CTCF
mediated adaptations in astrocytes in vitro. Finally, given the putative significance
and clinical relevance of elevated dopaminergic signaling aberrations in models of
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substance use disorders, as well as the essential and active roles that astrocytes
play in CNS physiology, approaches aiming to understand and restore astrocytic
control of dopaminergic homeostasis in brain regions critical for development and
maintenance of drug-taking behaviors warrant future investigation. Therefore,
exploring alternative strategies targeted at astrocytes to mediate withdrawal
symptoms and prevent relapse represent important future directions in basic
science and clinical research.
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